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Invasive lobular carcinoma(ILC) represents 5% to 15% of invasive breast 
carcinomas(1).  It is a distinct entity that is genetically and biologically different from 
invasive ductal carcinoma(IDC). It is the second most common type of breast 
carcinoma(2).  The term lobular carcinoma was introduced by Foote and Stewart in 
their seminal articles where they  described the characteristic loss of cellular  
cohesion,  bland cytologic features and diffuse infiltration(3). The loss of cellular 
cohesion described by Foote and Stewart has been shown in a molecular level to 
reflect inactivation of  E-cadherin  gene(3–5). Morphological features along with 
immunohistochemical (IHC) staining for E-cadherin is routinely used to differentiate 
ductal carcinoma from lobular carcinoma. Circumferential diffuse membranous 
staining of E-cadherin is the typical pattern in ductal carcinoma, whereas lobular 
cancers lack or show decreased E-cadherin expression. However, aberrant E-cadherin 
reactions have been described in breast carcinoma and include retained weak or partial 
incomplete thin membrane reaction in lobular-type tumours and reduced membrane 
reaction in ductal-type tumours(6,7). This was  seen in upto 15-20% of cases in 
published literature(7) . The reduction of E-cadherin stain in some high-grade 
infiltrating duct carcinoma and retained weak E-cadherin staining in some lobular 
neoplasia raise questions about using E-cadherin stain to distinguish lobular from 
ductal lesions. The distinction is especially important in the in- situ stage.  Lobular 
carcinoma in situ diagnosed by core or excisional biopsy requires no further surgery, 
whereas duct carcinoma necessitates complete surgical excision and possible 
additional radiotherapy(8).  Other immunostains that aid in the differential is p120 
catenin. Ductal carcinoma cells display membranous staining of p120 catenin whereas 
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lobular carcinoma cells show diffuse cytoplasmic staining of p120 catenin(9). Recent 
studies have shown that double labelling for E-cadherin and p120 catenin enhances 
the diagnostic accuracy. In this study we plan to retrospectively study the 
clinicopathologic features of lobular carcinoma cases diagnosed in our department. In 
addition, we plan to assess the utility of p120 and E-cadherin double immunostaining 
in diagnosing lobular carcinoma of the breast and compare it with E-cadherin 
immunostaining . 
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Aim of this study is to evaluate the clinicopathologic features of lobular carcinoma 
cases diagnosed in our department from January 2012 to September 2016.  We also 
aim to compare the utility of double immunostaining (p120/E-cadherin) with single 
immunolabelling with E-cadherin in diagnosis of Lobular carcinomas. 
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OBJECTIVES 
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1.  To do a detailed clinical and histomorphological study of lobular carcinoma cases 
diagnosed in our department from January 2012  to September 2016  and to further 
subclassify the different variants of  lobular carcinoma.  
2.  To study the utility of p120 catenin/ E-cadherin double labelling 
immunohistochemistry in diagnosing in-situ and invasive lobular carcinoma and 
compare it with E-cadherin immunohistochemistry when used as a single antibody.  
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Invasive Lobular carcinoma represents 5% to 15% of invasive breast carcinomas (1, 
2). The incidence of ILC has increased relative to IDC (1). The tumour was first 
described by Foote and Stewart in 1941(10).The term „lobular neoplasia‟ was first 
introduced to encompass a spectrum of in situ neoplastic proliferations including 
atypical lobular hyperplasia (ALH) and lobular carcinoma in situ(LCIS), which 
describe different levels of involvement of individual lobular units(11). The 
descriptions ALH and LCIS are widely used to classify these lesions since they confer 
different relative risks (4- to 5-fold and 8- to 10-fold, respectively) for the patient to 
subsequently develop invasive lobular cancer(12). 
Clinical and radiological features : 
Common presenting symptom is a palpable mass with irregular margins. They occur 
mostly in premenopausal women. Most of these cases are diagnosed between 40 and 
50 years of age(13). There appears to be a particularly increased risk of ILC in 
patients receiving hormone replacement therapy. All quadrants can be involved but 
ILC occur more commonly seen in central area. Rendi et al. studied 93 cases of LN 
and stated on the basis on imaging findings, 74 %, 24 %, and 2 % of cases were 
detected by mammograms, magnetic resonance imaging (MRI) and US, 
respectively(5). Microcalcifications were the most common finding, occurring in 69 % 
of cases, followed by pathological MRI non-mass enhancement in 16 %, masses in 14 
%, and architectural distortions in 1 % of cases. 
On mammography, ILCs can be present as asymmetrical, ill defined, irregular masses 
or densities. Calcifications are not commonly seen in ILC(2).Therapies for breast 
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cancers are changing very fast with our understanding of the molecular evolution of 
the disease. The diagnosis of the majority of  neoplastic breast lesions by light 
microscopy is a relatively straight-forward task for the surgical pathologist, 
therapeutic demands are resulting in increasing demands on the pathologist to 
correctly diagnose the specific types of breast neoplasia so that appropriate risk 
assessment and prognostic and predictive tests will be performed and appropriate 
therapies instituted. The broad categories of ductal and lobular carcinomas of the 
breast represent the majority of important breast lesions, but there are marked 
differences in morphology, molecular alterations, and treatment strategies for each 
category and within each category. The diagnostic discrimination between ductal and 
lobular carcinomas is important in several circumstances for therapeutic purposes. 
Invasive ductal carcinoma is composed of monoclonal proliferation of cohesive 
epithelial cells, which usually cause mammary ductal expansion. The IDC tumour 
cells range from low to high grade and are cohesive with preservation of membranous 
E-cadherin expression.  The Invasive lobular carcinoma cells are usually uniform and 
dyscohesive with low nuclear grade and scant cytoplasm (7, 8). ILC lack membranous 
E-cadherin immuno-positivity. Distinguishing lobular from ductal neoplasia is a task 
for which reproducibility data shows a k value that is moderate at best(6,14). A 
diagnosis of invasive lobular carcinoma on breast core biopsy may, depending on 
patient suitability for breast conserving therapy, necessitate magnetic resonance 
imaging of the breast to determine the extent of disease for purposes of obtaining 
negative margins for breast conserving therapy(1,8). Lobular carcinomas tend to have 
a poorer response to primary chemotherapy compared with ductal carcinomas. 
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Although there seemingly is a plethora of antibodies in the diagnostic armamentarium 
of the surgical pathologist, less than a handful of antibodies are useful in identifying 
breast carcinomas in metastatic sites.  
Histopathology 
Atypical lobular hyperplasia/ lobular carcinoma in situ  
Both ALH and LCIS can be defined by using the criteria given by Page and 
colleagues by a population of cells that are small, round, monomorphic, dyscohesive 
with an increased nuclear to cytoplasmic ratio; ALH is diagnosed when <50% of the 
acini in the affected terminal duct lobular unit are involved by the lobular proliferation 
and these cells do not completely occlude the lumen or produce marked distension of 
the acini(14). LCIS is diagnosed when >50% of the acini in the affected terminal duct 
lobular unit are completely filled and distended by the cellular proliferation(9). ALH 
and LCIS often coexist, and it can be difficult to differentiate ALH from LCIS. 
Intracytoplasmic vacuoles are often present in both ALH and LCIS and can be a 
prominent feature. Some of the cells have clear vacuoles, known as intracytoplasmic 
lumina or magenta bodies(15). When these magenta bodies are found in a Fine needle 
aspiration(FNA) biopsy they are suggestive of lobular lesion. Mitotic figures and 
necrosis is very rare. Pagetoid spread which is another characteristic feature is also 
commonly seen. Occasionally  in some cases cloverleaf pattern which is ductal 
involvement by lobular cells also can be seen. Sometimes LCIS can colonize pre-
existing breast lesions such as sclerosingadenosis, radial sclerosing lesions, 
papillomas, fibroadenomas, and collagenous  spherulosis which leads to confusion. 
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Variants of LCIS: 
Several variants of LCIS have been recognized. These include pleomorphic LCIS, 
pleomorphic apocrine LCIS, LCIS with comedo necrosis and carcinoma in situ with 
mixed ductal and lobular features. Clear cell and signet ring cell variants of LCIS have 
also been described. 
Classic LCIS: 
It is a distension of lobules with a monomorphic proliferation of discohesive 
epithelium exhibiting round shape, centrally placed nuclei and mild nuclear atypia and 
enlargement. Cellular discohesion refers to the loss of normal adherence between 
cells. This is manifest as a rim of space in between individual LCIS tumor cells(16). 
This is a major feature of lobular differentiation.  
Intracytoplasmic vacuoles or a signet ring appearance may be present. There may be a 
distinct thin pink rim that outlines the intracytoplasmic vacuoles; and the vacuoles 
may contain a dot-like material, producing a targetoid appearance. Vacuoles and 
signet ring formation can be helpful clues of lobular differentiation since these are not 
usual features of ductal lesions. LCIS is frequently a lobulocentric process but it can 
extending to ducts or, as discussed later, it can be a purely ductocentric process. At 
low magnification, lobulocentric  LCIS presents as a cluster of enlarged acini filled 
and expanded by tumour cells, much like a cluster of grapes. Ductocentric LCIS may 
present in a number of different growth patterns. In longitudinal section, minimal 
involvement of a duct may present with a pagetoid pattern alternatively, florid 
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involvement may fill and expand the duct.In cross-section, minimal involvement of a 
duct mayproduce bulbous outpouchings of the duct that resemble a cloverleaf. 
Pleomorphic LCIS : 
It was described as a distinct entity by Eusebi et al in 1992.Sneige et aldescribed in 
detail the morphological features of pleomorphic LCIS not associated with invasive 
lobular carcinoma(10). The cytological appearances of these cells are quite different to 
those of classic LCIS. Although the cells appear dyscohesive as in classic LCIS, they 
show a higher degree of nuclear pleomorphism and usually have abundant cytoplasm. 
Their cytoplasm may appear eosinophilic and finely granular, giving the cells an 
apocrine appearance (pleomorphic apocrine LCIS). Central comedo necrosis and 
calcifications are quite commonly associated with this lesion and can be confused with 
comedo ductal carcinoma in situ (DCIS).  
 
LCIS with Comedo Necrosis: 
Lobular carcinoma with comedo necrosis has recently been described. Ductocentric 
LCIS may cause marked expansion and filling of the duct accompanied by central 
necrosis(11,12). The degree of central necrosis may range from focal to extensive. 
Calcification may also be associated with necrosis.  This pattern can mimic comedo-
type DCIS. Diagnosis  of LCIS might not be considered if the characteristic pattern of 
lobulocentric LCIS is not present. One clue to lobular differentiation is discordance 
between the degree of nuclear atypia and presence of necrosis. Most comedo-type 
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DCIS exhibit tmoderate or severe nuclear atypia and pleomorphism, whereas LCIS 
with necrosis exhibits monomorphic nuclei with mild atypia. LCIS with necrosis has 
to be distinguished from DCIS(13,14). Some in situ lesions show features that 
resemble both LCIS and DCIS. These lesions are composed of small, monotonous 
cells typical of LCIS, but appear more cohesive(20). These lesions may resemble 
DCIS with the formation of microacinar-like structures but display loss of cohesion 
typical of LCIS.  
 
Mixed Ductal and Lobular: 
These cases often are comprised of small, monotonous cells typical of LCIS, but 
appear more cohesive(17). They resemble DCIS architecturally with the formation of 
microacinar-like structures but display loss of cohesion typical of LCIS(18). 
These tumours are hypocellular and composed of small to medium sized dyscohesive 
cells, which are individually dispersed in a fibrous connective tissue or arranged in 
single-file or linear cords. Classic ILCs invade the breast parenchyma without 
destruction of residual ductal-lobular structures, often with limited host reaction. 
Desmoplasia or lymphocytic reaction are not common features. The infiltrating cells 
frequently present a concentric pattern around normal ducts, a feature known as 
targetoid growth pattern. Cytologically the cells have round or notched ovoid nuclei 
with low grade nuclear atypia and a thin rim or slightly more abundant cytoplasm. 
Intracytoplasmic vacuolations are characteristic of lobular cells, sometimes leading to 
a signet-ring cell appearance. Mitotic figures are not readily found.  
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Histological variants of ILC: 
ILCs have been classified according to structural features in histological subtypes 
named trabecular, alveolar and solid variants.  These structural variants indicating 
would have distinct prognostic implications, with the solid variant indicating a worse 
prognosis. The trabecular growth pattern is characterized by invasive tumours similar 
to classic ILCs but composed of broader bands of cells instead of single file cell 
pattern(3).  In the alveolar pattern the tumour cells are arranged in globular aggregates 
of atleast 20 cells separated by thin bands of  fibrous  stroma.  The solid pattern is 
characterized by large sheets of  uniform cells with lobular morphology with little 
intervening stroma. The homogeneity of the tumour cell population, the cellular 
dyscohesivenessand the presence of intracytoplasmiclumina are useful diagnostic 
clues. The 'classic' variant of ILC have a lower incidence of axillary lymph node 
metastases (P = .0005)(23).This variant is more pleomorphic  and having a higher 
mitotic rate. Different growth patterns can occur in same tumour, the tumour should 
be classified as an ILC of mixed type.   Histological grade has an independent 
significant impact on the prognosis of ILC, and it should be taken into consideration 
when planning the postoperative treatment in this group of patients(19). 
Tubulolobular variant: 
It is a unique type of invasive breast carcinoma which shows both ductal and tubular 
differentiation. Fisher et al. came to a conclusion that this lesion represents a tubular 
variant oflobular invasive carcinoma in 1977(20). Tubulo-lobular carcinoma is a rare 
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variant of invasive breast cancer and displays small, round tubules and cords of small 
cells arranged in diffuse and targetoid pattern. These tubules typically lack apical 
snouts and are smaller and less angulated than those seen in tubular carcinoma. The 
overall infiltrative pattern is highly reminiscent of classical ILC. The neoplastic cells 
are uniform with small rounded nuclei and inconspicuous nucleoli.  
Signet ring cell variant: 
 This is a mucin rich aggressive carcinoma, which shows a prevalence of 2 to 4.5%. It 
has a high risk for metastatic spread. To call it as signet ring cell carcinoma >20% of 
the tumour cells should show signet ring morphology(21). These cells are arranged in 
loose or dyscohesive clusters with a variable size-small to intermediate, with large 
eccentrically placed nuclei with abundant cytoplasmic mucin(22). There is moderate 
anisonucleosis with moderate to marked hyperchromasia. Occasional cytoplasmic 
vacuolation can be seen. The targetoid pattern of classical invasive lobular carcinoma 
and Indian file pattern may also be seen here. 
Histiocytoid variant: 
These tumours composed of sheets of pale histiocyte-like cells with abundant,  finely 
vacuolated to granular cytoplasm and inconspicuous cell membranes interspersed in 
the breast parenchyma. Often the term „ground-glass‟ has been used to describe the 
cytoplasm(17). Nuclei are centrally or eccentrically placed which is generally dark to 
vesicular(18). Nucleoli can be indistinct in nature. Mitoses are generally sparse. 
Nuclear pleomorphism is mild to moderate, with mostly grade 1 to 2 nuclei  as 
described(23). Cytoplasmic vacuoles can rarely be seen. The cells are disposed 
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individually or in loose aggregates, without obvious glandular 
differentiation.Sometimes  cells can be arranged in a „targetoid‟ pattern.(3, 6, 9,22). 
Accompanying lobular neoplasia (atypical lobular hyperplasia or lobular carcinoma in 
situ) may be seen sometimes. 
Pleomorphic variant:  
This variant is characterized by dissociated cells arranged  in a loosely cohesive 
pattern(24). Occasionaly it displays intracytoplasmic mucin vacuoles (targetoid 
mucin). Cells display a higher degree of cellular pleomorphism and brisk mitotic 
activity and nuclear  hyperchromasia, nuclear membrane irregularities and prominent 
nucleoli(25). The presence of abundant eosinophilic cytoplasm which suggests 
apocrine differentiation confirmed by positivity with gross cystic disease fluid protein 
15 (GCDFP-15), a marker of apocrine differentiation(26).Pleomorphic lobular 
carcinomas  were frequently ER- and PR-positive, E-cadherin-negative and 
occasionally HER2- and p53-positive(27).The smears are cellular and the cells are 
arranged predominantly in a dyshesive pattern, occasionally forming a few, small 
aggregates(26). Tumour cells display significant nuclear pleomorphism, prominent 
nucleoli, and abnormal chromatin distribution. Cytoplasm is abundant, pale to 
eosinophilic, and can be granular or vacuolated.  Although the pleomorphic subtype is 
of biological interest, it does not appear to be of prognostic value(28). 
The development of breast cancer is a multistep process which originates from 
terminal duct lobular units (TDLUs) and progressing towards invasive cancer(20,35). 
The four precursor lesions are atypical ductal hyperplasia (ADH), atypical lobular 
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hyperplasia (ALH), lobular carcinoma in situ (LCIS), and ductal carcinoma in situ 
(DCIS)(29). The low grade tumors include tubular, cribriform, lobular and 
tubulolobular carcinoma (TLC) allof which have a favorable prognosis, possibly a 
consequence of fewer genetic changes(26). They frequently show recurrent loss of 
chromosome 16q and gain of 1q, positive expression for estrogen receptor (ER) and 
glandular differentiation. The high grade malignancies of the breast shows a greater 
degree of nuclear atypia and are frequently associated with negative for hormonal 
receptors. These tumours generally carry complex genetic alterations such as loss of 
8p,11q,13q and gain of 1q, 5p and 17q. Sometimes amplification of 6q22 and 8q22 
are also seen(30). There is frequent coexistence of columnar cell lesions with low 
grade DCIS with some overlapping features. These findings suggest that columnar cell 
lesions are potential precursors for low grade DCIS and invasive carcinoma(22). Loss 
of chromosomal material of 16 q is seen in well and intermediately differentiated  
DCIS. This shows LCIS and well differentiated DCIS have common  evolutionary 
pathways(31). 
. 
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Figure 1: Evolutionary pathways of low grade breast neoplasia 
. [taken  fromAbdel-Fatahet al,(22)] 
 
 
Molecular basis for the morphological characteristics  of lobular carcinoma: 
Molecular studies have been instrumental in highlighting the role of E-cadherin 
inactivation in the development of lobular lesions. E-cadherin, the protein product of 
the CDH1 gene (16q22.1), is a member of the calcium-dependent adhesion (ie, 
cadherin) family of transmembrane proteins, whose expression is found in epithelial 
cells(32). E-cadherin is an adherens-type of junctions and that forms homodimers in a 
calcium-dependent manner with other E-cadherin molecules of the adjacent cells( See 
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Figure-1). E-cadherin is composed of an extracellular, a transmembrane, and an 
intracytoplasmic domain. This intracytoplasmic domain is the juxtamembrane domain, 
which binds p120 catenin and a catenin-binding domain, which interacts directly with 
beta-catenin.  
Beta-catenin in turn binds to alpha-catenin, a-actinin, and vinculin, which establish a 
direct link between the cadherin-catenin complex and the actin cytoskeleton(33). The 
catenins are normally located at the junction of the cytoplasm and internal aspect of 
the cell membrane where they link E-cadherin with the actin cytoskeleton(34). In 
normal breast tissue the E-cadherin is located on the membrane and the catenins are 
located at the inner membrane area. Thus normal breast duct epithelial cells and IDC 
show diffuse and strong membranous stain for both E-cadherin and p120 catenin.  In 
ILC, on the other hand, there is loss of  membranous E-cadherin and the inner 
membranous distribution of p120 catenin, which gives the dyscohesive morphology of 
ILC. The loss of membranous distribution of  both  E-cadherin and p120 catenin are 
concurrent. The loss of E-cadherin in ILC also results in the loss of α-, β- and γ-
catenins, and p120-catenin becomes up-regulated and re-localised to the 
cytoplasm.Increased cytoplasmic p120 catenin activates a series of cytoplasmic Rho-
GTPases resulting in increased cell motility(7–11). IHC analysis of epithelial cells 
lacking E-cadherin reveals cytoplasmic rather than membrane localization of p120 
catenin(9). Neoplastic lobular proliferations (in situ and invasive; classic and 
pleomorphic types) characteristically show loss or marked down-regulation of the 
transmembrane protein E-cadherin in approximately 85% of cases, whereas luminal 
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epithelial cells and most ductal proliferations (ADH, DCIS, and IDC) exhibit positive 
staining by immunohistochemistry(9). 
 
 
p120 Catenin: 
p120ctn, initially described in association with E-cadherin as a tyrosine kinase 
substrate  was localized to chromosome band 11q11.  It was originally identified as an 
Src-tyrosine kinase substrate(9).  The α and β catenins are complexed with the 
carboxy-terminal cytoplasmic tail of E-cadherin and the p120ctn is anchored to E-
cadherin in a juxta-membranous site. p120 is not just a static structural component of 
the junctional complex, but rather p120 is actively involved in the status of cell 
motility, E-cadherin trafficking, E-cadherin turnover, promotion of cell junction 
formation and regulation of the actin cytoskeleton(30). p120ctn is detectable in the 
cell membranes of a wide variety of epithelial and nonepithelial tissues by 
immunohistochemistry, but predominates in virtually all types of epithelia.  Like beta-
catenin and plakoglobin these proteins are involved in mediating cell-cell 
adhesion(35).In mammalian cells, the presence of p120ctn promotes the assembly of 
the junctional complex with E-cadherin within the cell membrane. Overexpression of 
p120  recruits endogenous kinesin to N-cadherin thus dissociates the interaction 
between N-cadherin and p120 that  leads to a delayed accumulation of N-cadherin at 
cell-cell contacts during calcium-initiated junction reassembly(36). E-cadherin is 
necessary and sufficient for recruitment and stabilization of p120ctn.  Uncoupling of 
P120ctn and E-cadherin results in disruption of the tight junction and restoration of 
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coupling restores the tight junction(37).  p120ctn that is bound to E-cadherin exists in 
equilibrium with a small cytoplasmic pool of p120ctn. When E-cadherin is absent, the 
cytoplasmic pool of p120ctn increases(38), which in turn sets into motion a chemical 
cascade that results in increased cell motility. Specifically, increased cytoplasmic 
P120ctn as occurs in the absence of membrane E-cadherin causes a decrease in the 
cytoplasmic activity of GTPases(39), RhoA, and increases cytoplasmic activity of 
Cdc42 and Rac1, all of which work to increase cell motility. The morphology 
correlates with dispersed dyscohesive cellular anatomy of invasive lobular carcinoma. 
Sarrio et al has proven that p120ctn had a cytoplasmic localization in casesofinvasive 
lobular carcinoma(40), whereas ductal carcinomas showed reduced membrane 
p120ctn but no appreciable cytoplasmic p120ctn accumulation(39).  
Mastracci et al1 demonstrated cytoplasmic relocation of p120ctn in early lobular 
neoplasia and invasive lobular carcinoma(37). 
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Figure 2: E-cadherin mediated cell-cell adhesion. 
 
E-cadherin homodimers expressed on the plasma membrane of adjacent cells interact 
in a zipper-like manner. 
The intracellular adhesion Complex, which consists of alpha catenin, beta catenin, 
gamma catenin and p120, links E-cadherin homodimers to the actin cytoskeleton [ 
taken from Rafael de Deus Moura et al (41). 
 
E-cadherin:  
ILCs are characterized by the loss of membranous E-cadherin expression(42). E-
cadherin membranous positivity does not preclude the diagnosis of a lobular 
carcinoma. E-cadherin function in  lobular breast cancer can be disrupted due to  
37 
 
germline mutations and  epigenetic silencing by DNA methylation(43).  In case of E-
cadherin downregulation, α- and β-catenins are rapidly degraded  via an adenomatous 
polyposis coli–dependent mechanism  that ultimately targets β-catenin for destruction 
by the proteasome. Some LCIS and ILCs may display aberrant E-cadherin 
membranous expression. E-cadherin inactivation or downregulation occurs through a 
combination of genetic, epigenetic, and transcriptional mechanisms(44). Loss of 
chromosome 16q is usually accompanied by truncating mutations or gene promoter 
methylation leading to biallelic inactivation of the gene and loss of protein expression. 
Recent massively parallel sequencing studies of invasive breast cancers have 
confirmed a statistically significant association between lobular carcinomas and 
CDH1 gene mutations.  Identical CDH1 truncating mutations have been found in 
LCIS and associated ILC supporting the role of LCIS as a precursor for ILC. The loss 
of protein expression  accompanied by E-cadherin DNA alterations in lobular 
carcinoma in situ(4). 
 
Gene expression profiling in lobular carcinoma: 
LNs and ILCs are more likely to be diploid than ductal tumours (45). Indeed, 
chromosomal and array-based comparative genomic hybridisation (aCGH) analyses 
have defined, on a gross scale, the genomic profile of lobular carcinomas - in short, 
they harbour fewer chromosomal changes than ductal carcinomas and are generally 
less complex. Genomic losses, such as at 16p, 16q, 17p and 22q, and gains at 6q were 
detected in LN by chromosomal CGH (30). The key alterations identified more 
recently by aCGH in classic LCIS, florid/extensive LCIS and PLCIS are 1q gain and 
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16q loss, with increased genomic complexity observed in the latter two groups of 
lesions, including loss of 8p, 11q and 17p and amplifications at 11q13 (CCND1) and 
17q12 (ERBB2) . Like their pre-invasive counterparts and ER-positive IC-NST, both 
classic and pleomorphic ILC exhibit a high frequency of gain of chromosome 1q and 
loss of 16q (46–48), and it has been reported that all ILCs lose at least part of 16q 
(48). Other recurrent alterations include losses at 8p23-p21, 11q14.1-q25, and 13q, 
gains of 8q and 16p, and high-level amplifications at 1q32, 8p12-p11.2, and 
11q13(49). Although some candidate genes in the various regions have been 
postulated (for example, FGFR1 in 8p12-p11.2 and CCND1 in 11q13 (50), no 
definitive data confirming the drivers contained in these various regions have been 
reported specifically for lobular breast cancer. This is likely a result of the complexity 
of the chromosomal changes and the context-dependent nature of some of these 
alterations. Numerous candidate oncogenes have been identified in these regions but 
not specifically for lobular tumours - for example, ZNF703 gene amplification at 8p12 
specifies luminal B breast cancer (51). As mentioned above, PLC contains a similar 
profile of chromosomal change, although there is increased complexity and additional 
amplifications are present - 8q24 (MYC), 17q12 (ERBB2/Her2) and 20q13, which are 
usually considered to be archetypal changes of high-grade ductal tumours (52). Some 
attempts have been made to classify tumour genome profiles based on genomic 
architecture as either simple, complex-firestorm or complex-sawtooth. The genomes 
of both classic and pleomorphic ILC are generally classified as simple (in that they 
frequently harbour 1q gain and 16q loss and few other alterations) or complex-
firestorm (relating to the additional presence of complex, high-level amplifications at 
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the stated loci). It is conceivable that those ILCs that are classed as complex-firestorm 
have a worse prognosis, though this has yet to be explored. 
 
Pitfalls in the diagnosis of LCIS: 
Co-existence of DCIS and pleomorphic LCIS in the same slide or even in the same 
duct may occur. Again, if two morphologic patterns of in situ carcinoma are present 
and one appears to be pleomorphic LCIS, E-cadherin is advised to rule out the 
possibility that the other pattern is DCIS. LCIS involving collagenous spherulosismay 
mimic cribriform DCIS. The key thing is to recognize the features of collagenous 
spherulosis (pink collagenous or blue mucinous spherules surrounded by the thin 
waxy pink myoepithelial cell cytoplasm and nucleus); this will allow for excluding 
consideration of DCIS(53). When LCIS involves sclerosing adenosis, it can mimic 
invasive cancer. Thismay occur in two settings: First, if the sclerosing adenosis is 
extensive and already on its own resembles infiltrative growth, the superimposed 
LCIS may contribute further to the mimicry of invasive cancer. Second, if the LCIS is 
florid within the sclerosing adenosis, the LCIS- expanded acini/ducts may appear to 
coalesce and give the appearance of a solid sheet of invasive carcinoma. Recognition 
of sclerosing adenosis in the periphery of such lesions should be a clue to exercise 
caution and consider myoepithelial immunostaining before diagnosing invasion. 
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Pitfalls in the diagnosis of ILC:  
The most common differential diagnosis of ILC is invasive ductal carcinoma with 
lobular features (IDC-L). This type of IDC with lobular features has similar 
architecture, histology, and hormone receptor profile. Clues to the diagnosis of IDC-L 
are slightly larger tumor cells and small nests. However, IDC-L often has infiltrative 
growth mimicking ILC. Both these entities  can be differentiated via E-cadherin 
expression. Whereas IDC-L is positive for E-cadherin, ILC typically shows loss of E-
cadherin expression.  Other rare entities that differ in treatment but morphologically 
resemble ILC and may involve the breast include metastases of signet ring carcinomas 
from other primary sites, sclerosing epithelioid fibrosarcoma, myeloid sarcoma, 
mucosa-associated lymphoid tissue lymphoma, and plasma cell dyscrasias. 
 
Diagnosis of lobular carcinomas and role of immunohistochemistry:  
Diagnosis of lobular carcinoma is made on the basis of characteristic histologic 
features of a dyscohesive infiltrate of mostly small tumour cells. Loss of e-cadherin 
immunostaining has been traditionally used in aiding the diagnosis.  However, recent 
studies have shown that up to 15% of ILCs retained membranous E-cadherin 
expression (9).  In such cases, p120 catenin immunostain will help. The expression 
pattern of  p120 catenin can be used to differentiate lobular from ductal lesions(54).  
p120 catenin show membranous localization by immunohistochemistry in normal 
luminal epithelial cells and most ductal proliferations. In lobular lesions,  p120 catenin 
displays a cytoplasmic localization(55).  In a study by Rakha et al, all cases of lobular 
carcinoma including the cases which showed aberrant membranous expression of e-
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cadherin, showed strong cytoplasmic positivity for p120 catenin indicating the 
usefulness of the immunostain in the diagnosis of lobular cancers (11).The 
cytoplasmic expression of p120 catenin indicates a dysfunctional e-cadherin molecule, 
even if it is expressed by immunohistochemistry (11, 12). Dabbs et al found strong 
cytoplasmic staining for p120 catenin in 100% of their ILC cases and 0% of their IDC 
cases (5). Brandt et al found strong cytoplasmic staining for p120 catenin in 100% 
cases of LCIS and 88.7% of their ILC cases and weak cytoplasmic staining in 
remaining 11.3% cases. There was no cytoplasmic staining in ductal carcinoma cases 
(13).   About 10% of the IDC cases in the study however showed weak membrane 
staining for p120 catenin, unlike the strong membrane p120 catenin staining seen in 
majority of the IDCs.  Brandt et al concluded that both e- cadherin and p120 catenin 
are equally effective when used alone (13).  However, utilisation of both markers has 
been considered to be the best diagnostic strategy for lobular carcinoma. (12) 
Recent literature shows studies where double labeling techniques have been used for 
p120 catenin and E-cadherin (12). Double labelling can be applied in daily practice on 
paraffin-embedded tissue and is especially useful in small biopsies with small foci of 
CIS lesions and it showed 100% concordance with single antibody immunostaining 
using either E-cadherin or p120 catenin antibody. These studies also found that this 
double labelling  may enhance accuracy and confidence in the differential 
diagnoses(10,12).  Because of the small tissue volume, and even smaller volume of 
lesions picked up on screening, the number of IHC stains which can run a biopsy may 
be limited. To solve this problem, they developed a cocktail 
immunostainingcomposed of two primary antibodies raised against E-cadherin and 
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p120 catenin from rabbit and mouse, respectively. The two primary antibodies were 
then detected using secondary antibodies conjugated with different colors of 
chromogen(58).  Thus only one slide is required for the double staining with E-
cadherin and p120 catenin. 
 
Significance of diagnosis of in situ lobular carcinoma : 
The distinction of lobular carcinoma in situ from ductal carcinoma in situ has 
important therapeutic implications(53). Patients with the former are closely followed 
up without intervention, whereas, in latter case, complete eradication of the lesion is 
important (11,2).According to current guidelines, when LCIS is diagnosed on a core 
biopsy, a multi-disciplinary approach with careful clinicoradiological and pathological 
correlation is warranted to exclude any associated high risk lesion. Not all cases of 
LCIS diagnosed on a core biopsy need surgical excision.  The same applies for LCIS 
diagnosed on an excision specimen, even when the lobular neoplasia involves the 
margins.  A close mammographic follow up is recommended. Since some of 
LCISaremorefrequentlyassociated with  adjacent invasive lobular carcinoma, such as 
the pleomorphic variantorcomedo-typeLCIS, excision appearswarranted when these 
variants are found in a core biopsy(59). Similarly, LCIS presenting with a 
mammographicstructural abnormalityshould be excised to exclude invasive 
carcinoma. LCIS is associated with increased risk of subsequent invasive lobular 
carcinoma, with equal predisposition in either breast. The minimum risk of developing 
ILC after LCIS is 7.1% at 10 year(60).So excisional biopsy of lobular carcinoma in 
situ, atypical lobular hyperplasia or lobular neoplasia only when it is associated with a 
43 
 
synchronous mass lesion or there is a discordance between radiologic findings and 
pathology(61). 
 
Clinical significance of diagnosis of invasive lobular carcinoma:  
ILC tends to be more often bilateral and multicentric when compared to IDC. The 
variant is also known to metastasise to unusual sites like peritoneum, leptomeninges 
and visceral organs in the gastrointestinal and gynaecologic tracts (12). Metastases 
were found more frequently in ILC than in IDC in the bone (P=0.02) and/or in various 
other sites (peritoneum, ovary, digestive tract, skin  ) (P<0.001)(62).In terms of tumor 
size, 14% of ILCs were found to exceed 5 cm as compared with only 9.1% of 
IDCs(45). In a study  done by KalnishaNaidoo et al, showed that 93% of ILC 
diagnosed in core biopsies show complete agreement between core and excision and 
hence MRIs is not necessarily performed.(60) 
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MATERIALS AND METHODOLOGY 
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Materials and Methods: 
 This was a retrospective study done on cases diagnosed as lobular carcinoma (both in 
situ and invasive) over the period from January 2012 to September  2016.  The 
archived slides and blocks were retrieved and slides were reviewed and pathologic 
features recorded.  Clinical details were obtained from electronic database. The study 
was carried out in Christian Medical College, Vellore in the department of General 
pathology. Invasive lobular breast cancers diagnosed in the department during the 
period January 2012 to September 2016 were retrieved using key word search of the 
electronic pathology database. Biopsies without sufficient material for evaluation were 
excluded from the study. 
 
 
Retrieval   of  lobular carcinoma cases diagnosed from  Jan2012- September2016( ~71 
Cases) 
Review of all slides and recording of clinical and pathologic features 
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The clinical details were recorded from the electronic medical records and case sheets. 
The haematoxylin and eosin stained slides were reviewed and histopathological details 
were recorded.  E-cadherin slides where available were reviewed.  Few cases, where it 
was not available, immunostaining for E-cadherin was done on freshly cut sections 
and staining graded( intensity, pattern and proportion of positive tumour cells). 
Freshly cut sections were stained for double immunolabelling by E-cadherin and p120 
markers and staining graded (intensity, pattern and proportion of positive tumour 
cells). Utility of both the staining methods was compared. 
We had 71 cases from 62 patients, 9 of whom had bilateral tumours. 
Of the 71 tumours, 38 had only core biopsies, 25 had core biopsy and resections(20 
were mastectomy, 5 were WLE), 8 had only slide and block which were submitted for 
review.  Of the resections 10 were prechemo and 15 were post chemo. 
Clinical features recorded were  laterality of the tumour, bilaterality and 
multicentricity if present and whether or not neo adjuvant therapy was administered. 
Gross features were noted from the Pathology electronic database and included size, 
consistency and colour of the tumour. 
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Histopathological features: 
Detailed histopathological study was done on 71 cases by evaluating the archival 
Hematoxylin and Eosin stained slides.  The findings were noted in the proforma with 
relevant patient details. For those cases in which slides were not available, fresh 
sections were taken from the block. The slides were initially reviewed for histologic 
parameters by CC, and then further reviewed by both CC and MTM together on a 
double-header microscope. This combined review helped in eliminating observer bias. 
The following were the histological parameters evaluated.The observations were 
recorded in a Microsoft Excel worksheet.  
 
Patterns: Under low power, we looked for various patterns of ILC. 
The patterns recorded were single cell, Indian file pattern,  nests  and  targetoid  
pattern. Among  these patterns many were in combinations of various patterns. 
These  combinations  were noted. 
 
Dyscohesiveness: The characteristic feature of ILC is lack of cohesion. This is 
defined as separately lying tumour cells. This feature was observed under high power. 
Mitosis: Mitosis is an infrequent finding in case of  ILC. All the slides were scanned 
for Mitosis under high power objective. 
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Lymphocytic reaction: Lymphocytic reaction is one of the good prognostic factors. 
The presence or absence of lymphocytic reaction around tumour cells were noted. 
 
Intracytoplasmic lumen: One of the characteristic feature of the ILC is 
intracytoplasmic lumen. Its presence or absence were noted. 
 
Signet ring cell: Signet ring cells are a common feature for ILC. These cells have 
bland eccentrically placed nuclei, inconspicuous nucleoli and abundant amount of 
vacuolated cytoplasm. The presence or absence of signet ring cell morphology among 
tumour cells were noted.   
 
Tubule formation: Tubule formation is rarely seen in ILC. Tubules are structures 
formed by malignant ductal epithelial cells with polarised nuclei surrounding a central 
lumen. 
 
Nuclear pleomorphism: It is defined as variability in shape and size of the cells. It is 
a feature of all the malignant neoplasms. Nuclear pleomorphism was graded 1-3 
depending on the variability and size and shape of nuclei, presence of prominent 
nucleoli. 
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Histological grading:  Histological grading was done according to modified Bloom 
Richardson grading ( see appendix). 
 
Desmoplasia: This term denotes growth of fibrous connective tissue around a tumour. 
Tumour desmoplasiawas seen in many of our cases and it was noted. 
 
Variants of ILC: The ILC variant in each case was noted and was categorised under 
one of the following : Classical, tubulolobular, solid, pleomorphic and histiocytoid . 
 
LCIS:Presence  or absence of associated Lobular carcinoma in situ was noted. 
Pagetoid spread:  Presence or absence of Pagetoid spread of LCIS component was 
noted. Pagetoid spread in LCIS is defined as malignant cells extending along the ducts 
between intact overlying epithelium and underlying basement membrane. 
Elastosis: It is one of the degenerative changes in the dermal connective tissue with 
increased amounts of elastotic material, usually in periductal or perivascular location 
or around tumour cell clusters. This finding is common in ILC. 
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Adjacent breast changes: Adjacent breast tissue was examined for pre neoplastic and 
non-neoplastic alterations including ductal carcinoma in situ, Atypical lobular 
hyperplasia, usual ductal hyperplasia, intraductal papillomatosis, Columnar cell 
changes and flat epithelial atypia. Presence or absence of calcification was also noted. 
 
Lymphovascular invasion: Presence or absence of lymphovascular invasion was 
looked for in the periphery of the tumour and the presence or absence was noted.  
 
Lymph nodes: Total number of excised lymph nodes and number of positive lymph 
nodes were noted. 
 
Immunohistochemistry for E- cadherin: E-cadherin is regularly used to distinguish 
between ILC and Invasive ductal carcinoma.  Absence of E-cadherin staining is a 
diagnostic feature of ILC. However, aberrant positivity for E-cadherin has been 
reported in ILC. Cases with aberrant positivity were recorded. The aberrant positivity 
was classified into one of the following staining patterns: discontinuous membrane 
staining, continuous membrane staining, dot like positivity and cytoplasmic positivity. 
E-cadherin slides were available in 50 of the 71 cases. Percentage of positive cells , 
intensity and pattern of staining was recorded. Percentage of positive cells  was 
rounded off to the closest multiple of 10. 
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Double immunostaining for E-cadherin/p120was carried out on the blocks (37cases) 
according to standard procedure (appendix). Double immunostainingwas done on  
biopsies/ tissues taken prior to neoadjuvant therapy to avoid any treatment effects on 
staining. 
p120: Intensity and localisation  of staining and proportion of positive cells were 
recorded for p120.  Intensity of p120 was graded as mild, moderate and marked and 
given the score as 1, 2 and 3. Localisation of the staining recorded as cytoplasmic and 
membranous. Proportion of positive cells (was recorded as percentage of total number 
of cells) and was rounded off to the closest multiple of 10. A total score combining 
proportion score and intensity score was given for p120 immunostaining akin to the 
Allred score for hormone receptor assessment (See appendix).  Internal controls 
(normal ducts) were assessed for membrane staining for p120. 
 
E-cadherin: Staining intensity, pattern and percentage of positive cells for e-cadherin 
in the double immunostaining method was also recorded as mentioned earlier. 
Utility of both staining methods were compared and the concordance between two 
methods were noted.  
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Statistical methods  
Sample size: The aim of the study was to compare between   p120 & E-cadherin 
double immunohistochemical staining with E-cadherin immunostaining  on all cases 
of Invasive lobular carcinomas between the period of Jan 2012 to September 2016. 
The difference in the sensitivity of the tests is approximately 10% in published 
literature. Ideal sample size was calculated as 73 with an alpha error of 5%. The 
sample size was calculated using n Master software version 2.0. However, due to non-
availability of paraffin blocks and insufficiency of tissue in the blocks, double 
immunostaining could be done only on 37 cases.  
Categorical variables were summarised as frequencies and percentages. Quantitative 
variables were summarised as mean and standard deviation for normally distributed 
variable or median and IQR for skewed variables. The Chi square test was used to 
compare the proportions in the two categorical variables and the Independent t-test 
was used to compare the means between two groups. Diagnostic accuracy were given 
with 95% confidence interval. For all the analysis, 5% level of significance will be 
considered to be significant. All the statistical analysis were done using stata/ic v.13. 
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RESULTS 
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The study included 71 tumours from 62 patients, 9 of whom had bilateral tumours.   
The cases were diagnosed between January 2012 and September 
2016.Histomorphological and clinical details were studied in 71 cases. 50 cases had E-
cadherin immunostaining done. Double immunostaining for E- cadherin/ p 120 was 
done only on 37 cases due to non availablity of tissue blocks or insufficient material 
remaining in the paraffin blocks.  
 
Nature of specimen: Of the 71 tumours, 38 had only core biopsies, 25 had core 
biopsy and resections(20 were mastectomy, 5 were WLE), 8 had only slide and block 
which were submitted for review.  Of the resections 10 were pre-chemotherapy and 15 
were post chemotherapy. 
Of the 71 tumours, 70 cases were invasive lobular carcinoma. One case had only 
lobular carcinoma in situ arising in a benign phyllodes tumour.  
 
Gender: All tumours were in female patients. There were no cases of lobular 
carcinoma of male breast. 
 
Side of the breast:  In this study we had 28 left sided and 34 right sided breast 
tumours. Nine patients had bilateral tumours. 
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Age:  Of the 62patients, one patient‟s age was not known. The mean age of the 
remaining 61 patients was  51.96years with a standard deviation of 11.95 years.  The 
age ranged from 20-85 years with a median of 49.0years .66 % of patients cases had 
age more than 40 years. 
 
 
  
 
 
Figure 3: Box plot showing age distribution 
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Bilaterality: Invasive lobular carcinoma has the predilection to involve bilateral 
breasts. In our study of 62 patients, 9 had bilateral  tumours (12.68 %). 
 
 
Figure 4: Frequency of  bilateralityin invasive lobular carcinoma 
 
 
Unicentric/Multicentric:  There were no cases with multicentric tumour in our study.  
 
 
Size : Mean size of the tumours were 3.47cm with a median of 3.50 and standard 
deviation of 1.64cm . 
Gross features: The cut surface of the tumours were predominantly grey-white  and  
the tumours had a firm consistency. 
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Histomorphology of lobular carcinoma 
Pattern of arrangement of tumour cells:  The most common pattern observed in our 
study was single cells, seen in 67 of the 70 tumours. The second most common was 
Indian file pattern which was observed in 65 tumours. The third common pattern was 
nests, seen in 40 cases ( 57%). ( See fig.3) (See fig. 4). 
 
 
 
 
Figure 3: Common patterns seen in invasive lobular carcinoma.Y axis denotes 
number of cases. 
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Various combinations of multiple patterns were seen in every case.   The most 
common combination was Indian file, single cells and nests. The next most common 
combination was Indian file and single cells and the third most common was 
Targetoid,Indian file and single cells. (See fig.6) In 2 cases, pattern could not be 
studied due to paucity of tissue. 
 
 
Figure 4 Combinations of multiple architectural  patterns. Y-axis denotes 
number of cases. 
 
 
Nuclear pleomorphism:  Nuclear pleomorphism was noted in 68 of71 cases. In 3 
cases, pleomorphism was not assessed due to paucity of tissues. 19 cases showed  
mildpleomorphism( nuclear score 1), 47 cases showedmoderatepleomorphism( 
nuclear score 2) and two cases showed marked nuclear pleomorphism( nuclear score 
3). 
Tubules:  One case had score 1 for tubules, 10 cases( 14.28%) had  score 2 and rest of 
57 cases had been given score 3. 
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Mitosis: We had 63 cases which had a score of 1 for mitosis, 2 cases had given a 
score of 2 and 3 cases had given score 3. 
 
Table 1: Summary of the scores histological grading : 
 Score 1 Score 2 Score 3 
Nuclear 
pleomorphism 
19 47 2 
Tubules 1 10 57 
Mitosis 63 2 3 
 
Cumulative score according to Modified Bloom Richardson grading system  
5 cases had a cumulative score of 5, 58 cases had a cumulative score of 6, 3 cases had 
cumulative score of 7 and 2 cases had a cumulative score of 8. 
 
Figure 5: Distribution of modified Bloom Richardson cumulative score 
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Histopathological grading:  According toScarff- Bloom-Richardson system(See 
Appendix),8.82% of the cases were grade 1, 88.24% were grade 2 and 2.94% 
cases were grade 3. 
 
Intratumoral lymphocytic infiltrates:  Lymphocytic  reaction is commonly found in 
ILC. 59 of 71 cases showedlymphocytic reaction. 
 
 
 
Figure 6:Frequency of Intratumoral lymphocytic infiltrates 
 
 
Desmoplasia:  Tumour desmoplasia was present in 68 of our cases. 
 
 
Elastosis: We had 51(71.83%) which show elastosis. 
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Histological variants of ILC.: Subtyping was done in 69 cases. 64 cases were 
categorised as Classical variant (92.75%), 3 as pleomorphic(4.34%), 1 as 
tubulolobular variant (1.43%) and 1 as histiocytoid(1.43%). 
 
 
 
Figure 7: Variants of Invasive lobular carcinoma 
 
 
LCIS: Associated LCIS was seen in 33 of our cases. In one case LCIS was seen 
involving sclerosingadenosis. One tumour had only LCIS without an invasive 
component, arising in phyllodes tumour.   
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Lymph nodes:   25 resection cases had axillary lymph node dissection,of this, 19 
cases had positive lymphnodes. The distribution of number of positive lymph nodes is 
shown in figure 10.   We had two cases which had 11 positive  lymph  nodes. 
 
 
 
Figure 8: Number of Positive Lymph nodes 
 
 
  
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 8 9 10 11
N
u
m
b
e
r 
 o
f 
ca
se
s 
Number of positive lymph nodes 
Lymph nodes  
63 
 
 
Proliferative changes in adjacent breast: Non-neoplastic alterations in adjacent 
breast seen included  usual ductal hyperplasia,  intraductal papillomatosis, columnar 
cell changes and occasional calcification. See table 1. 
 
 
 
Figure 9: Proliferative changes in adjacent breast 
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Lymphovascular invasion:  We had 28 cases(39.44) which showed 
lymphovascularinvasion , all of which were histologic grade 2. 
 
 
 
Figure 10 : Frequency of lymphovascular invasion 
 
 
Perineural invasion: 5 of our cases showed perineuralinvasion , all of which 
belonged to histologic grade 2. 
 
Skeletal muscle invasion: We had 4 cases which showed skeletal muscle invasion. 
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Table 2: Summary of histological findings 
Histological Findings Percentage 
ILC Variant  
Classical 92.75% 
Pleomorphic 4.34% 
Histiocytoid 1.43% 
Tubulolobular 1.43% 
Patterns  
Single cells 95.71% 
Indian file 92.86% 
Nests 57.14% 
Targetoid 10% 
LCIS 28.57% 
Proliferative changes in 
adjacent breast 
 
Intraductalpapillomatosis 5.63% 
Columnar cell changes 16.90% 
Ductal hyperplasia 5.63% 
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Table 3 :Summary of histological findings 
 
Histological features Numbers and percentage 
Desmoplasia 68(95.77%) 
Elastosis     51 (71.83%) 
Calcification 5 (7.14%) 
Skeletal muscle invasion 4(5.71%) 
Perineural invasion 5(7.14%) 
Lymphovascular invasion 28(39.44%) 
 
 
Immunohistochemistry:Immunohistochemistryfor E-cadherin alone was available 
for 50 cases. Freshly cut sections were stained for double immunolabelling by E-
cadherin and p120 IHC markers on 37 cases. The intensity, pattern and percentage of  
positive tumour cells was recorded in both methods.  Utility of both the staining 
methods was compared. 15 cases had both  E- cadherin staining and double 
immunostaining  for E- cadherin/p 120. 
 
 
 
 
 
 
 
 
67 
 
Results of Immunostaining for E-cadherin: 
 
E-cadherin immunostaining was available in 50 cases . 15 of the 50 cases (30 %) 
showed E cadherin positivity in the ILC component . 9 of these cases showed 
cytoplasmic staining, 4 showed only incomplete membranous staining and 1 case 
showed both incomplete membranous staining with cytoplasmic staining and one case 
showed both of the above staining patterns with dot like positivity. Pattern of aberrant 
staining and percentage of positive cells is given in Table 4. 
In the 50 cases where  E-cadherin was done, LCIS was present in 10 cases,4 of which 
showed positivity for E-cadherin.  
 
 
 
Figure 11:  E-cadherin immunohistochemistry in invasive lobular carcinoma 
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Clinical significance of E-cadherin positivity: 
We have compared age, percentage of  lymphovascular invasion, grading of tumours 
and number of positive lymph nodes with E-cadherin positive and negative cases. E-
cadherin positivity is not correlated with any of the above mentioned variables (Refer 
to table no 4) 
Table 4:  Summary of staining characteristics of E-cadherin in cases of E-
cadherin positive invasive lobular carcinoma( Single antibody staining) 
 
Serial no of cases Percentage positive cells Pattern 
1. 50 
Cytoplasmic 
Incomplete membranous 
2. 10 Cytoplasmic 
3. 60 Cytoplasmic 
4 100 
Cytoplasmic 
Dot like 
Incomplete Membranous 
5. 60 Incomplete Membranous 
6. 10 Cytoplasmic 
7. 50 Incomplete Membranous 
8. 5 Cytoplasmic 
9. 70 Cytoplasmic 
10. 50 Incomplete Membranous 
11. 60 Cytoplasmic 
12. 20 Cytoplasmic 
13. 5 Cytoplasmic 
14. 5 Cytoplasmic 
15. 20 Incomplete Membranous 
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Table 5: Comparison between E-cadherin positive and negative cases 
 
 
E-Cadherin 
Positive 
E-Cadherin 
Negative 
p.value 
Age 57.46 years 52.37 years 0.096 
Lympovascular 
invasion 
 33.33% 51.4% 0.239 
Grade 2 100% 94.29% 0.502 
Lymph node 
positive 
40% 42.86% 0.875 
 
 
 
 
Double Immunostaining for E-cadherin/ p120:  
Double immunostaining was done in  37 cases. 13 of these showed positive staining 
for E- cadherin.  Six cases had cytoplasmic staining, 7 cases had incomplete 
membranous pattern of staining. Two of the E-cadherin positive cases >66% of the 
cells stained positive, two cases had 33-66%  of cells positive  and rest of the nine 
cases had 1-10% cells positive. 
In all 37 cases  of ILC (100%) in which double immunostaining was done,  
cytoplasmic staining for p120 was demonstrated in the tumour cells. 13 cases showed 
weak cytoplasmic staining (1+), 16 of the cases showed moderate intensity (2+) of 
staining, 8 showed strong (3+)cytoplasmic staining.  Semiquantitative estimation of 
p120  of the invasive lobular carcinoma was done based on  a system akin to Allred 
scoring system, adding proportion and intensity score of the cytoplasmic p 120 
staining . (See appendix for scoring system).   
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In the thirty seven cases with double immunostaining,  16 had an LCIS component, 
and all of them (100%) were  positive for p120 staining. 5 of these cases had  
strong(3+) cytoplasmic positivity, 7 had moderate (2+) cytoplasmic positivity and 4 
cases had mild positivity (1+). The  LCIS component in all these cases had a  
proportion  score of 5(>66% of the cells stained positive). All 37 cases showed 
membrane staining for p120 and E-cadherin in normal ducts,  which served as internal 
controls. 
 
 
 
Correlation between the percentage of positive cells and intensity of p120: The 
following graph depicts the correlation between the percentage positive cells and 
intensity of grading. Thirteen cases had intensity of one. Of these 13 cases, 8 were 
given proportion score of 5. 16 of the cases with moderate intensity(2+) had 
proportion score of 5. 
 
 
 
Figure 12:  p120 - Intensity and proportion score in Invasive Lobular Carcinoma 
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Figure 13: Distribution of intensity of p120 staining in LCIS 
 
 
 
Table 6: Summary of intensity score and proportion score of p120 in in Invasive 
lobular carcinoma 
 
 
Proportion 
score 
2 
Proportion 
score 
3 
Proportion 
score 
4 
Proportion 
score 
5 
Number of 
cases with 
intensity 1 
1 1 3 8 
Number of 
cases with 
intensity 2 
---- ---- ---- 16 
Number of 
cases with 
intensity 3 
---- ---- ---- 8 
 
 
0
1
2
3
4
5
6
7
1 2 3
 N
u
m
b
e
r 
o
f 
ca
se
s 
Intensity 
Intensity of p120 in LCIS cases 
Number of cases
72 
 
 
Table 7:Summary of staining characteristics of double immunostaining for E-
Cadherin/ p120 in E- cadherin positive invasive lobular carcinoma 
 
Case Intensity pattern 
Percentage 
of positive 
cells 
p120 
percentage 
positive cells 
p120 
Intensity 
1 1 
Incomplete 
membranous 
20 90 1 
2 2 Cytoplasmic 80 90 2 
3 1 Cytoplasmic 10 90 2 
4 1 Cytoplasmic 5 100 3 
5 1 
Incomplete 
membranous 
10 100 2 
6 1 
Incomplete 
membranous 
5 80 2 
7 2 
Incomplete 
membranous 
60 100 2 
8 1 
Incomplete 
membranous 
40 100 2 
9 1 
Incomplete 
membranous 
70 100 2 
10 1 
Incomplete 
membranous 
5 100 2 
11 1 Cytoplasmic 10 50 1 
12 1 Cytoplasmic 5 100 3 
13 1 Cytoplasmic 5 100 3 
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Figure 14: Tumour cells arranged in Indian file pattern in invasive lobular 
carcinoma (H&E,200x)   
 
   
Figure 15 :  Tumour cells arranged in nests in invasive lobular carcinoma(H&E, 
100x) 
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Figure 16: Tumour cells are arranged in single cells in invasive lobular 
carcinoma (H&E, 400x) 
 
 
Figure 17: Perineural invasion(H&E, 400x) 
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Figure 18:Lymphovascular Invasion (H&E,100x) 
 
 
 
 
Figure 19: Invasive lobular carcinoma, histiocytoid variant(H&E, 200x) 
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Figure 20 Invasive lobular carcinoma histiocytoid variant(H&E, 400x) 
 
 
 
 
Figure 21: Invasive lobular carcinoma pleomorphic variant(H&E, 200x) 
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Figure 22: Invasive lobular carcinoma Pleomorphic variant(H&E, 400x) 
 
 
 
 
Figure 23 : Signet ring cells in invasive lobular carcinoma(H&E, 200x) 
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Figure 24: Lobular carcinoma in situ showing dyscohesivenessof  the  tumour 
cells(H&E at 200x) 
 
 
 
Figure 25: Phyllodes tumour involved by lobular carcinoma in situ(H&E at 100x) 
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Figure 26: Cloverleaf pattern in in situ lobular carcinoma( H&E,  200x) 
 
 
 
 
Figure 27:  Incomplete membranous pattern of E-cadherin in Invasive lobular 
carcinoma(E-cadherin, 400x) 
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Figure 28: Granular cytoplasmic pattern in E-cadherin Immunostaining,  400x 
 
 
 
 
Figure 29: Aberrant E-cadherin positivity in Invasive lobular carcinoma cells, 
targetoidpattern(E-cadherin at 200x) 
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Figure 30: Aberrant E-cadherin positivity - cytoplasmic dot like pattern (E-
cadherin at 400x) 
 
 
 
 
 
Figure 31: Aberrant E-cadherin positivity- granular cytoplasmic and Incomplete 
membranous pattern(400x) 
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Figure 32:  Internal control for  Double immunostaining for p120/E-cadherin – 
normal ducts with membrane staining for p120 and E-cadherin. (200x) 
 
 
F 
Figure 33: Cytoplasmic weak (1+) staining for p120 and incomplete membrane 
staining for E-cadherin (Double immunostaining for p120/ E-cadherin,  400x). 
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Figure 34:  Moderate (2+) cytoplasmic staining for p120 and negativity for E-
cadherin (Double immunostaining, 400x) 
 
 
 
 
Figure 35: Pagetoid spread of in situ lobular carcinoma with remnant ductal 
epithelium positive for E-cadherin and lobular carcinoma in situ cells staining 
weak cytoplasmic  p120. (Double immunostaining,100x) 
 
85 
 
 
 
Figure 36:Weak(1+) Cytoplasmic staining for p120 and aberrant  incomplete 
membrane staining for E-cadherin ( Double immunostaining, 400x) 
 
 
 
 
Figure 37: Strong (3+) cytoplasmic staining for P120 and negative E-cadherin 
(Double immunostaining, 400x) 
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Figure 38: Incomplete membrane staining for  E-cadherin and cytoplasmic p120 
staining in invasive lobular carcinoma cells (Double immunostaining, 400x) 
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DISCUSSION 
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Invasive lobular carcinoma represents  5-15% of all types of breast carcinomas(1). It 
is the second most common type of breast carcinoma(2).  It is important to make an 
accurate diagnosis of lobular carcinoma because it changes the prognosis and 
treatment of the patient. 
 
Identification of lobular carcinoma in situ may necessitate a patient into high risk 
follow up, whereas in case of ductal carcinoma in situ excision with proper margin 
and radiation therapy is treatment of choice(8). Mastectomy is preferred over 
lumpectomy in case of ILC than Invasive ductal carcinoma(63). E-cadherin 
immunostaining has traditionally been used to distinguish between ductal or Lobular 
carcinoma. 
 
 There are several drawbacks of using a single immunohistochemical stain like 
absence of the single targeted antigen in the tumour cells, false negative results  due to 
other factors like, quality of antibody, detection kit, procedural,  technical and human 
errors(64). Alternate antigens have been explored to identify these cases.  
Immunostaining for p120 catenin is one method.  Cytoplasmic location of p120 
staining has  been observed in lobular neoplasia(8). Double immunostaining with p 
120 catenin and E-cadherin has also been employed to increase the accuracy of 
diagnosis (64).  
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This 10 year retrospective study has been done to assess in detail the clinicopathologic 
features of lobular carcinoma in our setting.  We also aimed to assess the diagnostic 
utility of double immunostaining for p120 and e cadherin in a subset of these cases. 
 
CLINICAL FEATURES 
Age:  The mean age affected by invasive lobular carcinoma is  between 57-65 
years(1).  This age group is slightly older than the patients with Invasive ductal 
carcinoma.  In our study the mean age was 51.96 years.  There was no significant 
correlation found between tumour size and age of the patient.  
 
Risk factor:  It can be due to increased consumption of alcohol(65) .  But in case of 
ductal carcinoma alcohol is not a risk factor(66).  
 
Bilaterality: Invasive lobular carcinoma has the propensity towards bilateral 
presentation in almost  5-19% cases(67,68).  There is some evidence that incidence of 
bilateral tumours are higher in classical variant of ILC than in other variants of ILC.  
In our study there were 12.68% cases which had bilateral presentation. In this study 
women presented with ill-defined palpable mass as mentioned in other various studies. 
The rate of multifocality and bilaterality in lobular carcinomas are 50% and 30% 
respectively but in our study we did not find any multifocal cases(69). 
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Types of specimens:   
We had 71 cases from 62 patients, 9 of whom had bilateral tumours.Of these 71 
tumours, 38 had only core biopsies, 25 had core biopsy and resections(20 were 
mastectomy, 5 were WLE), 8 had only slide and block review (diagnosed outside).  Of 
the resections, 10 were pre chemo and 15 were post chemo. 
 
Gross Features:  In the 25 resection specimens, the gross features of the tumour were 
noted.  Majority of the tumours are grey white in colour with a firm cut surface( 
97.9%). The gross features of invasive lobular carcinoma have been variously 
described as numerous, hard nodules that can be felt as grains of sand in the breast 
parenchyma and as very ill circumscribed tumour with a diffuse growth pattern. 
Hence the difficulty in accurately measuring the tumour size (70).  The mean size of 
the tumour in the current study was 3.47cm.  There was no correlation between the 
tumour size and grade of the tumour in the current study. In a study by O‟Malley  et al 
there was a  positive correlation between the size and the grade of the tumour(71).  
In our study we had 38 core biopsies, 25 had core biopsy and resections(20 were 
mastectomy, 5 were WLE), 8 had only slide and block review (diagnosed outside).  Of 
the resections 10 were pre chemo and 15 were post chemo. 
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MICROSCOPIC FEATURES 
Architecture: One of the main characteristics of lobular carcinomas the  lack of 
cohesion of tumour cells. Singly lying cells dispersed in the stroma are often seen. The 
tumour cells also have a tendency to form a single line of dyscohesive cells, known as 
Indian file pattern.  Often, more than one of these patterns are present in single 
tumour.67 cases in this study (95.71%) had singly lying cells. 65 cases had Indian file 
appearance.  The single tumour cells sometimes perlocate around normal ductal 
structures in a concentric manner  this is known as targetoid pattern of growth(72). 
Inflammatory cells around the ducts sometimes mimic a targetoid pattern. This 
targetoid distribution is not associated with desmoplastic response. In our study, we 
had 7 cases which had targetoid distribution of tumour cells. There were various 
combinations of architectural patterns in the study cases. The most common 
combination of patterns seen was that of Indian files, single cells and nests. The next 
most common combination was that of Indian file and single cells and the third most 
common pattern was targetoid pattern, Indian file and single cells. 
 
Cytomorphological characteristics:  
The characteristic appearance of lobular carcinoma cells are round to ovoid nuclei, a 
thin rim of cytoplasm and an occasional  intracytoplasmic  lumen(65,73,74).  In this 
study, 63 cases (88.73%) showed cells with intracytoplasmiclumina. The common 
variants of invasive lobular carcinoma are classical, solid variant, pleomorphic 
variant, tubulolobular variant and mixed.  In our study we had 64 cases of classical 
variant of ILC, 3 cases of pleomorphic variant, 1 tubulolobular and 1 case of 
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histiocytoid variant.  In pleomorphic variant the nuclei is three to four times larger 
than a normal lymphocyte. Signet ring cells are also a common feature of invasive 
lobular carcinoma(75).  Scattered signet ring cells were seen in 67 cases. In 
pleomorphic variant there is occasional in situ ductal involvement by tumour cells 
which is known as „Clover leaf‟ appearance(76).  In this case study we had two cases 
where Cloverleaf pattern is noted.   
 
Histological grading: 
 Nottingham system is followed for histologic grading of ILCs. The relevance of the 
three tier grading system of Nottingham is a matter of controversy due to rarity of 
tubule formation in ILC. ILCs receive a grade 3 for tubule formation. Marked nuclear 
pleomorphism is a rare finding in ILC.  Nuclear grade for ILC is commonly 1 or 2. 
Nuclear pleomorphism is one of the components of grading system but there was no 
correlation between tumour size and lymph node status in a study by O‟ Malley et 
al(71). Mitosis is infrequent in ILCs. In a study of 171 invasive lobular carcinomas 
byDabbs et al, 20 % of the cases were grade I, 64% grade II and 16% grade III (15).  
We had 8.82% of grade 1 cases and 88.24% of grade 2 cases. We found only two 
cases (2.94%) of grade 3  in our study.  One case had score 1 for tubules, 10 cases( 
14.28%) had  score 2 and rest of 57 cases had been given score 3.Mitotic activity is 
infrequently seen in invasive lobular breast carcinoma(65).  However, other studies 
have found that mitotic activity in isolation is highly correlated with prognosis(71).  
Mitotic activity is the single most important factor which determines the stage and 
aggressiveness of the Invasive lobular carcinoma. Bane et al has proposed that mitotic 
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activity is the strongest predictor of survival  and it gives more information than the 
rest of the modified Bloom Richardson criteria(77). In this study we had 63 cases 
which had a score of 1 for mitosis, 2 cases had given a score of 2 and 3 cases had 
given score 3. 
 
Lymphocytic reaction: 
 Lymphocytic reaction is a very occasional finding in case of ILCs. Lymphocytic 
reaction affects generally the lobules which are infiltrated by the tumour cells and 
occasionally it can be seen throughout the ducts in the adjacent breast 
parenchyma(78).  However, in this study we had 59 cases (83.10%) cases in which 
lymphocytic reaction was found in the peritumouralstroma. Any degree of 
lymphocytic reaction was counted as positive in our study. This could be the reason 
for the high frequency.  
 
LCIS: 
Lobular carcinoma in situ foci  commonly accompany  classical variant of ILC(79).  
DisCostanzo et al. in their study found out that  LCIS was associated in 65% of 176 
cases of classical ILC(79).  In our study we found that 33 cases(46.48%)  had foci of 
LCIS.  LCIS is diagnosed when >50%  of the acini in the terminal duct is replaced by 
monomorphic cell proliferation(76).  Complete absence of lumen is not necessary. 
The characteristic feature of LCIS is dyscohesiveness of the tumour cells.  The  
tumour cells have  bland  round  to oval  nuclei,  inconspicuous  nucleoli and scant 
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cytoplasm. Presence of intracytoplasmic lumen is also a wellknowncharacteristicof 
LCIS. There are various types of LCIS like pleomorphic,  pleomorphic apocrine,  
LCIS with  comedo necrosis  and  mixed type of  LCIS(80).  It is common to see the 
extension of this lobular neoplasia  in between the myoepithelial cells and ductal cells.  
This is known as Pagetoid  spread.  We had 10 cases in which Pagetoid spread was 
present (14.08%).  When LCIS grows in a ductulocentric pattern with minimal 
bulbous outpouchings, it  gives a „ Cloverleaf ‟ appearance(76).  Two of our cases 
showed a cloverleaf appearance. One of our cases had only LCIS and the in situ 
component was seen involving a benign phyllodes tumour.  The reason behind this is 
induced by the changes in the stromal component (16).  Some other study showed it 
can be due to growth factors and hormones.  
 
Atypical lobular hyperplasia:  
 Atypical lobular hyperplasia is diagnosed when <50% of the acini in a lobule are 
affected by lobular neoplasia.  This is again predominantly due to loss of E-cadherin 
expression. Here cells are monomorphic population of polygonal to cuboidal cells. 
Cells are loosely cohesive and regularly spaced. Myoepithelial cells are admixed with 
malignant cells.Peritumoral lymphovascular invasion is reported to be  seen in 10% of 
the cases of invasive lobular carcinoma(70).  In this study we had 28 cases (39.44%)  
in  which lymphovascular  invasion  was  seen. Shrinkage artefact in the sections can 
appear as  lymphovascular  invasion. Lymphovascular invasion is more common in 
pleomorphic variant as per study done by Buchanan et al(81). Five of the cases 
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(7.14%) in our study showed perineural invasion. It is quite rare in cases of lobular 
carcinoma and has no prognostic significance(82).   
 
Lymph node metastasis: Lymph node metastasis is quite common in ILC.  
According to one study there are lesser number of lymph node metastasis associated 
with classical variant of invasive lobular carcinoma when compared to pleomorphic 
variant of ILC (70).  Invasive lobular carcinoma generally spreads through lymphatics 
or by hematogenous spread. The tumour cells mainly involves the sinuses and 
sometimes the lymph node parenchyma. It is difficult to detect the metastases when 
the infiltrate is sparse.  Even in cases with extensive lymphnodal  metastasis, it can be 
difficult to differentiate the metastasis from sinus histiocytosis, because of the bland 
nature of tumour cells.  Rarely,  the lymph node metastases can be concentrated in the 
sinusoids of hilum, (83). In this study we had 28 cases, where lymph nodes were 
excised and 19 of the cases were positive for lymph node metastasis. The growth 
patterns of  lymphnode  involvement have been reported to classified as nodular, 
diffuse and nodular and  diffuse(83).In  the 19 cases with lymph node metastasis,  
diffuse pattern was most common followed by nodular pattern. 
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Stromal reactions: 
Stromal desmoplasia was noted in  68 of our cases (95.77%). Elastosis was noted in 
51 of our cases(71.83%).   
 
Nonneoplastic/ preneoplastic alterations in adjacent breast: 
Columnar cell changes are well known for their  associations with lobular neoplasia. It 
comprise morphological changes in the duct epithelial lining, which gives it as a 
columnar cell appearance and it involves the terminal duct lobular unit(16). There is 
variable dilatation of the acini  which are lined by columnar epithelial cells. These 
columnar epithelial cells have often apical snouts.  There is very bland nuclei, 
minimal nuclear pleomorphism, fine chromatin and moderate amount of cytoplasm. 
Mitosis is very rare.   
The histological triad of tubular carcinoma, columnar cell lesions and lobular 
carcinoma is also known as Rosen triad.  Loss of chromosomal material on 16q and 
gains on 1q were detected in lobular neoplasia, similarly to columnar cell lesions, low 
grade DCIS, tubular carcinoma and ILC. This suggest a common evolutionary 
pathway for LCIS and ILC(2). Abdel-Fatah et al in their study had 60% of the cases of 
ILC  associated with columnar cell changes(22). In our study we had 12 cases which 
were showing columnar cell changes (16.90%) but none of the cases showed flat 
epithelial atypia. Loss of chromosomal material of 16q as a central event in well 
differentiated and intermediately differentiated DCIS. These results show a high 
genetic homology between LCIS and well differentiated DCIS(31). 
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Ductal hyperplasia can be either usual or atypical types. Usual ductal  hyperplasia 
show a streaming pattern of growth  particularly in the centre of the involved  spaces. 
In this study we had 4 cases of ductal hyperplasia. We had  one case which had 
coexisting DCIS. 
 
Molecular pathogenesis:  
 There is much evidence now that suggests that  alterations in the E-cadherin-Catenin 
complex play an important role in tumour behaviour and progression(85).  Defects in 
the several components of the E-cadherin complex result in decreased cell-cell 
adhesiveness and increased risk of tumour metastasis(85).  Invasive lobular carcinoma 
and Lobular carcinoma in situ(LCIS)  shows absence of E-cadherin expression, but in 
case of Invasive ductal carcinoma, E-cadherin expression is retained. Loss of E-
cadherin expression can be due to many factors such as inactivating mutations,  loss of 
heterozygosity and promoter hypermethylation(85). Transcriptional repression 
through activation of transforming growth factor-beta/SMAD2, this down regulates E-
cadherin expression(7). Behind this non functional E-cadherin  there are some 
unknown point mutations also seen(86).  Mutations in the E-cadherin have been found  
in  classical and pleomorphic variant of ILC(87).  There  is  a  protein truncating 
mutation in exon 21(66%)  of  32 ILCs(5).   
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E-Cadherin:   
E-Cadherin is an epithelium specific molecule which helps in cell to cell adhesion. 
Generally E-cadherin helps in distinguishing from ILC and IDC. In case of  ILC, E-
cadherin is absent or shows weak discontinuous staining. In case of IDC, it shows 
complete membrane staining.  Some of the high grade invasive ductal carcinoma cases 
show reduction in the intensity in staining and some Invasive lobular carcinomas have 
retained weak positivity. This results in difficulties in diagnosis.  The  aberrant 
staining pattern of E-cadherin in ILC can be recognised as partial or weak linear 
membrane staining,  complete membrane staining, dot like staining or cytoplasmic 
staining(88).  This aberrant staining  can be due to presence of non 
functionalEcadherin in the membrane(89).   
 
Qureshi et al reported 10% ILCs to be E-cadherin positive. (3).  Frequency of E- 
cadherin positivity in ILCs range from 2% to 29%.(6). The current study showed an 
aberrant positivity of 30% ( n=15) on  E-cadherin staining with single antibody.   Of 
these, 9 cases showed cytoplasmic pattern of staining and 2 had incomplete membrane 
pattern of staining.  Rest of the two cases had multiple patterns and one had all the 
three patterns like cytoplasmic, dot like  and incomplete membranous.  One of the 
cases showed complete membranous  positivity. 
 
In literature, different studies have shown variable degrees of aberrant staining of E-
cadherin(See table 7). This can relate to the difference in techniques of 
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immunohistochemistry like sections taken per case, thickness, different clones of 
antibody used and antigen retrieval system. Goldstein et al in their study of 143 cases 
of ILC with HECD-1 clone of E-cadherin showed complete absence of staining in 136 
of their cases but complete membranous pattern of staining in 7(5%) of their cases. 
Kowalski et al in their study of 8 cases of ILC showed 100% cytoplasmic positivity 
with HECD-1 clone of E-cadherin. Most of  the other studies had used HECD-1 clone 
of E-cadherin but the dilutions, antigen retrieval system, buffer ,pH, incubation and 
linking system were different for each study (88).  In our study heat induced antigen 
retrieval was done for 1 hour with incubation period of 40 minutes. The antibody used 
was Dako and the clone was NCH38. 
 
Clinical significance of E- cadherin positivity:  
In our study, there was no significant correlation between the  E-cadherin positive 
status and the age of presentation, lymphovascular invasion, grade  or lymph node 
metastasis. All 15 of the E -cadherin positive cases were grade 2 tumours. 
 
p120 immunostaining:   
Cateninsare  proteins involved  in  the connection between the E-cadherin membrane 
complex and intracellular  actin cytoskeleton.   In case of normal breast epithelial cells 
p120 catenin is present at the cell membrane .  If E-cadherin is lost or  becomesnon 
functional, p120 gets upregulated and  aggregates in the cytoplasm.  p120 exerts 
oncogenic properties  by regulating the Rho GTPases(90).  Immunohistochemistry 
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reveals  cytoplasmic localization rather than membrane in p120 staining(80).   The 
sensitivity for p120 in invasive lobular carcinoma is around 95% according  
Mastaracci et al(91).  In our study, sensitivity of p120 was 100%.  All our ILC cases 
stained for p120. More importantly, cytoplasmic staining for p120 was seen in all our 
cases which were positive for E-cadherin. p120 is localised to cytoplasm in cases of 
LCIS and metastatic Invasive lobular carcinoma as well(85).Dabbs et al in their study 
showed that 100% of ILC were positive for p120(92). 
 
Rakha et al found that 84% of ILC cases showed diffuse cytoplasmic positivity for 
p120 .  All these cases showed moderate to strong cytoplasmic positivity. The 
summary of relevant literature on p120 staining in lobular neoplasia is given in Table 
6.  These results reflect the transcriptomic analyses of lobular carcinoma that showed 
downregulation of actin cytoskeleton (93).  
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Table 8: Relevant studies on p120 staining pattern in lobular neoplasia 
 
Study Patterns ALH LCIS ILC 
Sarrio et 
al(90) 
Normal membrane 
 
----- ----- 9%(6/67) 
 
Reduced membrane 
 
----- ----- 3%(2/67) 
 
Cytoplasmic(Weak) 
 
----- ----- 23.9%(16/67) 
 
Cytoplasmic(Strong) 
 
90%(26/29) 100% 64.1(43/67) 
 
Cytoplasmic 
 
 
----- ----- 0%(0/67) 
Mastracci et 
al(91) 
Positive 
 
90.9%(10/11) 
 
100%(10/10) 
 
 
 
 
Negative 
 
9.1%(1/11) 0%(0/10) ----- 
Dabbs et 
al(9) 
Positive 
 
----- ----- 100%(64/64) 
 
Negative 
 
----- ----- 0%(0/64) 
Brandt et al 
Strong Cytoplasmic 
 
----- 100%(19/19) 88.7%(39/44) 
 
Weak cytoplasmic 
 
----- 0%(0/19) 11.3%(5/44) 
 
Cytoplasmic – 
 
----- 0%(0/19) 0%(0/44) 
Current 
study 
Strong Cytoplasmic 
positivity 
 
----- 31.25%(5/16) 21.62%(8/37) 
 
Moderate 
cytoplasmic 
positivity 
 
 43.75%(7/16) 43.24%(16/37) 
 
Weak cytoplasmic 
positivity 
 
 25%(4/16) 35.13%(13/37) 
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DOUBLE IMMUNOSTAINING 
 
 
There are several  drawbacks  of  using a single immunohistochemical stain like 
absence of the single targeted antigen in the tumour cells, false negative  due to other 
factors, quality of antibody, detection kit, procedural errors  technical and human 
errors.  Purpose of this study was to detect the utility of double immunostaining which 
would be particularly useful to pick up small foci of ILCs in biopsies where scarcity 
of the tissue has to be taken into consideration.  Loss of  membranous distribution of 
both E-cadherin and p120 are concurrent(64). 
 
.In the 37 cases of ILC in which double immunostaining was done, 13 cases showed 
aberrant positive staining for E-cadherin. Of these, six cases showed cytoplasmic 
positivity and 7 cases showed incomplete membrane staining.  The intensity ranged 
from weak to moderate.  Cytoplasmic staining for p120 was seen in all the 37 cases 
including the 13 cases which were positive for E-cadherin.  Hence, in our study 
sensitivity of  p120  is  100%.   
 The frequency of aberrant staining for E- cadherin in ILC in our study was 34% on 
double immunostaining and 30% with E-cadherin done by single antibody staining.  
This rate is higher than other published studies(4,36,94). This could be due to 
inclusion of cases with even very focal aberrant staining.   
 
In the study done by Dabbs et al scoring for E-cadherin was given as negative for no 
immunoreactivity, weak 1+ was given as any percentage of cells, 2+staining in <10% 
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and 3+ for >10% of cells(40).  In our study we have given 1+ score for any percentage 
of positive cells.In  a study done by LiL et al,  p120-catenin  was diffusely 
cytoplasmic positive for 66.7% of ILCs(95).Cytoplasmic  staining was detected in the  
absence of E-cadherin expression were observed 55.6%.   
 
All the 37 cases of ILC in which double immunostaining was done showed 
cytoplasmic staining for p120. For the p120 component of double immunostaining, we 
used a scoring system akin to Allred scoring system for semiquantitative estimation of 
the staining. 86.5% of our cases showed strong positivity in case of p120 staining.  Of 
the 37 cases, 16 had an LCIS component, all of which (100%) showed cytoplasmic 
staining for  p120. All the 16 LCIS caseswerepositive(100%) for p120 staining.   
There is only one published study in which double immunostaining for p 120/ E-
cadherin was done. This study included 12 cases, 100 % of cases showed p 120 
cytoplasmic staining and all cases were negative for E-cadherin(64). 
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Table 9: Comparison of literature on Aberrant E-cadherin immunoreaction in  
lobular neoplasia 
 
 
 
 
 
 
 
 
 
Publication 
Cases/ 
Diagnosis 
Complete 
absence 
Complete 
membrane 
Reduced/ 
Partial 
Focal 
IHC 
staining technique 
Moll et al 22 ILC 19(86.4%) ----- ------ 3(13.6%) 
Heat induced antigen 
retrieval(HIER)Citrate 
bufferAvidinbiotin 
complex(ABC) 
Goldstein et 
al(92) 
22  LCIS 20(91%) ----- ---- ----- 
HIER  
Citrate, pH 6 
Horseradish 
Peroxidase(HRP) 
Angeirsson  
et al(55) 
14 ILC 9(64%) 1(7%) ---- 4(29%) 
HIER (microwave) 
Citrate, pH 6 
HRP 
Goldstein et 
al(93) 
82 ILC 73(89.1%) ----- ----- 9(10.9%) 
HIER (steamer) 
EDTA, pH 7.5 
EnVision Plus 
Kovacs et 
al(94) 
16ILC 13(81%) ---- ---- 
3(19%) 
Cytoplasmic  
Staining 
HIER(pressure cooker) 
Citrate, pH 6.5 
ABC 
Acs et 
al(95) 
42 ILC  41 (98%) 1(2%) ------ -----  
Wahed et 
al(96) 
14 PILC  
 
12(86%) ----- ---- 2(14%) 
No Ag retrieval 
ABC 
Qureshi 
et al(3) 
49 ILC 5(10%) ----- ----- ------  
Current 
study 
 50  ILC ----- ------ 6(40%) 
9(60%) 
Cytoplasmic 
HIER 
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Table 10: Comparison of E-cadherin positivity between single immunostaining 
and double immunostaining. 
Serial no of 
cases 
Single E-cadherin and % 
positive cells 
Double E-cadherin and % 
positive cells 
1. Negative Negative 
2. Positive (20%) Negative 
3. Positive (40%) Negative 
4. Positive (20%) Positive (10%) 
5. Positive (5%) Positive (5%) 
6. Negative Positive (10%) 
7. Positive (40%) Positive (5%) 
8. Negative Negative 
9. Negative Negative 
10. Negative Negative 
11.. Positive (80%) Positive (60%) 
12. Positive (60%) Positive (70%) 
13. Positive (50%) Positive (10%) 
14. Positive (5%) Positive (5%)  
15. Positive (30%) Positive (40%) 
16. Positive(60%) Negative 
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In our study,  there were 16  cases where both double immunostaining for p 120/ E- 
cadherin and E- cadherin  immunostaining by single antibody was done. See Table 
(8). The concordance between the two methods for E-cadherin immunostainingwas 
75% . 
 
Utility of p120/E-cadherin double immunostaining over E-cadherin 
immunostaining for diagnosis of invasive lobular carcinoma 
In our study, cytoplasmic p120 staining was seen in 100% of invasive lobular 
carcinoma and in situ lobular carcinoma highlighting the high sensitivity of this 
molecule for diagnosis of lobular neoplasia.  The cytoplasmic p120 staining was seen 
in all cases which showed aberrant E-cadherin positivity,  emphasising its usefulness 
in the diagnosis.  Although we did not study p120 staining in invasive ductal 
carcinoma, all our cases showed membrane staining for p120 in normal ducts which 
served as internal controls. Double immunostaining for p120/ E-cadherin would be a 
very useful technique to distinguish lobular neoplasia from ductal carcinomas, 
especially in small biopsies.  This is especially important in cases of in situ neoplastic 
proliferations where the distinction between lobular and ductal has great relevance in 
therapeutic decision making.  
 
 
 
 
 
107 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
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This was a retrospective study on cases diagnosed as lobular carcinoma from 
January 2012 to September  2016. Clinicopathological and histomorphological 
features were studied and utility of  E-cadherin immunostaining and dual 
immunostaining with p120/E-cadherin was  compared.  
1. We studied 71 tumours from 62 patients, 70 were invasive lobular carcinoma. 
One was a case of lobular carcinoma in situ.  
2. The mean age of presentation in our study was 51.96 years and mean tumour 
size was 3.47cm.  
3. The frequency of bilaterality was 12.68%. This is correlating with the 
literature. 
4. 64 cases (92.75%) were classical variant. We had three cases of pleomorphic 
variant of ILC, one tubulolobular and one histiocytoid variant.  
5. Single cell pattern as most common architectural pattern(95.71%) followed by 
Indian file pattern (92.86%). 
6. Invasive lobular carcinoma was associated with LCIS in 46.48% of cases. In 
one case which had only lobular carcinoma in situ, the in situ neoplasia was 
seen involving a phyllodes tumour.  
7. Lymphovascular invasion was seen in 28 cases(39.44%), all of which were 
grade 2 tumours. 
8. We had one case of coexisting high grade DCIS associated with Invasive 
lobular carcinoma. 
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9. Aberrant E-cadherin staining was seen in 30% of invasive lobular carcinoma. 
We noted different patterns of aberrant staining, cytoplasmic being the most 
common (60%) followed by incomplete membranous pattern(40%). Two cases 
show multiple aberrant patterns like dot positivity, incomplete membranous 
and cytoplasmic staining. 
10.  In dual immunostaining for p120/E-cadherin, cytoplasmic p120 positivity was 
seen in all 37 cases in the invasive and in situ lobular carcinoma components 
resulting in a sensitivity of 100%.  Cytoplasmic staining for p120 was seen in 
all cases which showed aberrant E-cadherin staining, reiterating its utility in 
diagnosing lobular neoplasia. All 37 cases showed membrane staining for p120 
and E-cadherin in normal ducts,  which served as internal controls. 
11.  Double immunostaining for p120/E-cadherin will be especially useful in small 
biopsies with scanty foci of  in situ/ invasive carcinoma to determine its lobular 
phenotype which will affect management decisions. 
12. The concordance rate between single and dual immunostaining for E-cadherin 
in our study was 75%. 
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Limitations 
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Limitations: 
1. Immunohistochemistry was not done in all the 71 cases due to non avaialability 
of paraffin blocks and paucity of tissue in the available blocks.  Hence the 
statistical significance of the results of the immunohistochemical tests could 
not be calculated. 
2.  We did not include cases of Invasive ductal carcinoma as control, so the  
specificity, positive predictive value and negative predictive value of the 
double immunostaining method could not be calculated. However membrane 
staining for p120 in normal ducts and lobules showed the utility of cytoplasmic 
p120 staining in diagnosing neoplastic lobular proliferations. 
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       Protocol for automated immunostaining: 
1. Paraffin embedded tissue sections were cut at 4μ thickness and floated in poly L-
lysine coated slides and incubated overnight at 37˚C. 
2. These slides were then treated with 4% milk solution for 10 minutes to eliminate 
the hydrophobic effect and give positive charge to the slides. 
3. Then the slide labels were bar coded and the labeled slides were loaded in 
Ventana Benchmark XT autostainer (a fully automated immunostainer). 
4. Individual protocols have been designed in the software attached to the machine 
for each marker. Specific protocols were selected according to the marker. 
5. A standard protocol was used for most of the markers with a minimal variation 
for few individual markers. The steps included in this protocol were as follows:  
a. Deparaffinization 
b. Liquid coverslip application. 
c. Heat induced antigen retrieval by treating with standard CC1 solution (pH 
patent with the company) for one hour at 90˚C. 
d. Then the primary antibody(E-cadherin) was added and incubated for 40 
minutes @ 37˚C. 
e. Then the secondary antibody (Multimer) was added and incubated for 8 
minutes. 
f. Finally the slides were counterstained with Haematoxylin and incubated 
for 8 minutes, followed by incubation with the bluing reagent for 4 
minutes. 
(From antigen retrieval till counterstaining, in between every step the 
slides were washed with reaction buffer. The whole process is 
automated). 
Then the slides were brought to 80% alcohol (2 changes) to remove the liquid coverslip 
and then dried and mounted in DPX. 
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DUAl Stain 
Tissue taken on positively charged slide 
↓ 
Slide baked in hot air oven at 37*Degrees overnight 
↓ 
Then print the dual stain barcode label and stick to slide. 
↓ 
Then load the slide and both the detection kit (DAB & Red) 
Steps  
Depraffinization – EZ prep 
↓ 
Antigen retrival – CC1 solution either (short, Mild, standard) 
↓ 
Blocking -. UV DAB inhibitor 
↓ 
First Primary added (this would take DAB as chromogen)(E-cadherin) 
↓ 
Then secondary antibody (p120) 
↓ 
DAB chromogen 
↓ 
DAB enhancer 
↓ 
Second Primary antibody added (Red chromogen) (p120) 
↓ 
Then Secondary antibody (p120) 
↓ 
Red chromogen 
↓ 
Counterstain with Haematoxylin 
↓ 
(Wash steps in-between all the steps) 
↓ 
Then slides are rinsed in mild detergent  
↓ 
Alcohol and xylene 
↓ 
Cover slipped with DPX. 
1. First added Primary would give brown color DAB 
2. Second added Primary would give Red color. 
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Allred scoring system: 
Proportion score Percentage 
positive cells 
Intensity 
score 
Remarks 
0 NIL 0 None 
1 1% 1  Weak 
2 1-10% 2 Intermediate 
3 10-33% 3 Strong 
4 33-66%   
5 66-100%   
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PROFORMA 
 
Retrospective study of infiltrating lobular carcinoma of breast with assessment of utility 
of  P120 catenin and E-cadherin double immunostaining in the diagnosis. 
 
Serial no:       Biopsy no: 
 
Age:        Gender: M/F 
 
CLINICAL: 
 
Side of  the breast: 
 
Unilateral/Bilateral: 
 
Unifocal/Multifocal: 
 
Prechemo/Postchemo: 
 
Nature of specimen:   Core biopsy    WLE    Resection 
 
GROSS: 
 
Tumour size:    
 
Cut surface:        colour   consistency 
 
MICRO: 
 
Cohesiveness: 
 
Pattern: Targetoid growth Indian file        Nests           Single cells 
Mitosis:       +             /               - 
Lymphocytic reaction:   +             /               - 
Intracytoplasmic lumina: +             /               - 
Signet ring cells:   +             /               - 
Intracellular mucin:  +             /               - 
Nuclear pleomorphism:  +             /               - 
Desmoplasia:   +             /               - 
 
ILC variant:  Classical       Trabecular       Solid          Alveolar              Pleomorphic        Tubuloalveolar  
Scarff-Bloom Richardson Grade – Nuclear grade score    Tubule Pleomorphism 
Cumulative score 
LCIS: Present /Absent 
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Adjacent Breast: Elastosis: 
Columnar cell change: 
Calcification: 
Intraductal papillomatosis: 
Pagetoid spread: 
Total  number of lymphnodes: 
Number positive: 
pTNM staging: 
 
 
IHC: 
 
E-Cadherin    (ILC) 
Localisation Pattern Intensity % pos cells 
    
 
E-cadherin(LCIS) 
 
 
Localisation 
 
Pattern 
 
Intensity 
 
% pos cells 
 
    
Internal controls ( normal breast ducts) 
 
Double immunostaining e- cadherin and p120 catenin 
stain localisation pattern intensity % pos cells 
e-cadherin     
P120 catenin     
 
Internal controls ( normal breast ducts) 
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slno studyslno biopno age gender sob unibil unimul prepost specimen tumoursizecolor consist targetgrowindianfile nests singelcels tulu mitosis lymreac intralum signetring intramucinnuclpleo desmoplasductalhyp ilcvariant mitosis1 tubule pleomor total cumuscorelcis lymphovasskeletal elastosis ccc calcifi intrapap pagetoid lymphnodesnumpos ptnmstag internal ilcecad ilclocal ilcinten ilcposcell lcisecad lcislocal lcisinten lcisposcel diecad interecad dilcecad dilclocal dilcinten dilcposcel dlcisecad interecad1dlcislocal dlcisinten dlcisposcedip120 dilcp120 interp120 dilclocal1 dilcinten1dilcposce1dlcisp120 interlcis dlcisloca1 dlcisinte1 dlcisposc1 ILC prprtn LCISprptn
1 1 5709/12 47 2 1 1 1 1 3 1 1 2 2 2 2 2 2 2 2 2 2 1 2 2 1 1 2 2 1 2 1 1 1 2
2 2 7179/12 46 2 2 1 1 1 1 4 1 1 2 1 1 1 1 1 1 1 1 2 1 1 2 5 1 3 2 6 2 1 2 2 1 2 2 2 2 14 11 pT2N3Mx 1 2
3 3 8310/12 46 2 2 1 1 2 3 1 1 2 1 2 1 2 1 1 1 1 1 1 1 2 1 1 3 2 6 2 1 1 2 1 1 2 2 1 0 0 1 2 2 1 2  1 1 1 1 1 99 1 1 1 2 99 5 5
4 4 28949/12 20 2 2 1 1 2 1 1 1 2 2 2 2 1 1 1 2 1 1 2 1 1 3 2 6 2 2 2 2 1 2 2 2 1 1 2
5 5 11151/13 60 2 1 1 1 1 1 2 2 1 1 2 1 1 2 2 2 1 1 2 1 1 3 2 6 2 1 1 2 2 2 2 2 1 2 2 1 2 1 1 1 1 1 90 5
6 6 13972/13 54 2 2 1 1 1 1 1 2 1 1 1 2 1 1 1 1 2 1 1 1 5 1 3 2 6 2 2 2 2 2 2 2 2 2 T4bN3cM1 1 2
7 7 24869/13 54 2 1 1 1 1 1 2 1 2 1 2 1 1 1 1 1 1 2 1 1 3 2 6 2 2 1 2 1 1 2 2 2 1 2
8 8 3980/14 49 2 2 1 1 1 3 2 1 2 1 2 1 1 1 1 1 1 2 1 1 3 2 6 2 2 1 2 1 2 2 2 2 12 11 ypTxN3Mx 1 2
9 9- 36697\13 49 2 1 2 1 1 1 2 1 1 1 2 1 1 1 1 1 1 2 1 1 3 2 6 2 1 1 2 1 2 2 2 2 11 4 pTxN3aMx2 1 2
10 10 37118\13 36 2 2 1 1 1 3 3.5 1 1 2 1 1 1 2 1 1 1 1 1 1 2 1 1 3 2 6 2 1 2 2 1 2 2 2 1 13 0 pT2N0Mx
11 11 37927/13 59 2 1 1 1 1 3 2 1 1 2 1 1 1 2 1 1 1 1 1 1 2 1 1 3 2 6 2 1 1 2 1 2 2 2 2 9 0 pT1cN0Mx 1 1 1 1 20 2
12 12 198/14 42 2 1 1 1 1 1 8 1 2 2 1 1 1 2 1 1 1 1 1 1 2 1 1 3 2 6 2 1 2 2 1 2 2 2 2  
13 13 4634/14 56 2 2 1 1 1 3 6.5 1 1 1 1 1 1 2 1 1 1 1 1 1 2 1 1 3 2 6 2 1 1 2 1 1 1 2 1 14 9 pT3N2Mx 1 2 2 1 2 2 1 1 1 1 1 3 99 1 2 1 3 99 5 5
14 14 8129/141 44 2 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 1 1 3 2 6 2 1 1 2 1 2 1 2 2 1 2 1 1 1 2 1 20 1 1 1 1 1 90 5
15 15 8129/142 44 2 1 2 1 1 1 2 1 2 1 2 1 1 1 1 1 1 2 1 1 3 2 6 2 2 2 2 1 1 1 2 2 1 1 1 1 25
16 16 18006/14 48 2 1 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 1 1 1 1 3 2 6 2 2 2 2 1 1 2 2 2 1 1 1 2 2 80 1 1 1 1 2 90 5
17 17 26434/14 61 2 2 1 1 1 4 3.5 1 1 2 2 1 1 2 1 1 1 1 1 1 2 1 1 3 2 6 2 1 2 2 2 1 2 1 2 1 2 2
18 18 507/15 38 2 1 1 1 2 3 0.5 1 1 2 1 2 1 2 1 1 1 1 1 1 2 1 1 3 2 6 2 2 2 2 1 2 2 2 2 1 2 2 1 2 1 1 1 1 2 90 5
19 19 4512/15 71 2 1 1 1 1 1 3.5 1 1 2 1 1 1 2 2 1 1 1 2 1 1 2 1 1 3 2 6 2 2 1 1 1 2 2 2 2 12 4 pT2N2aMx 1 1 1 1 20 2 1 2 1 1 1 1 1 90 5
20 20 6233/15 66 2 2 1 1 2 3 2 1 1 2 1 1 1 2 2 1 1 1 1 1 2 1 1 3 2 6 2 1 2 2 1 2 2 2 2 9 0 pT1cN0Mx 1 2 2 1 2 1 1 1 1 2 90 1 2 1 3 90 5 5
21 21 16289/13 72 2 1 1 1 1 4 2.8 1 1 2 1 1 1 2 2 1 1 1 1 1 2 1 1 3 2 6 2 2 1 2 1 2 2 1 1 14 3 pT2N1a 1 1 1 1 40 2 1 2 1 1 1 1 2 80 5
22 22 10487/151 85 2 2 2 1 1 1 2 1 1 1 2 2 1 1 1 1 1 2 5 1 3 2 6 2 2 2 2 1 2 2 2 2 1 1 1 1 20 1 1 1 2 1 10 1 1 1 1 3 99 5
23 23 10487/152 85 2 1 2 1 1 1 2 1 1 1 2 2 1 1 1 1 1 2 1 1 3 2 6 2 2 2 2 1 2 2 2 2 1 1 2 1 5 1 1 1 2 1 5 1 1 1 1 2 99 5  
24 24 18421/15 46 2 1 1 1 1 3 2 2 2 2 2 1 2 2 1 2 2 2 2 2 2 2 2 2
25 25 32916/15 46 2 1 1 1 1 1 6.5 1 1 1 1 1 1 2 2 1 1 1 2 1 1 2 1 3 3 2 8 2 1 2 2 1 2 2 1 1 8 8 ypT3N2aMx
26 26 22965/15 50 2 1 1 1 1 3 1.1 1 1 2 1 2 1 2 1 1 2 1 1 1 2 1 3 3 2 8 2 1 1 1 1 2 2 2 2 14 10 pT1cN1aMx 1 2
27 27 23429/15 66 2 2 2 1 1 3 1 1 1 2 1 2 1 1 2 2 1 1 1 1 2 1 3 2 1 6 2 2 2 2 1 2 2 2 2 2 1 1 1 1 1 1 70 5
28 28 23463/15 66 2 1 1 1 1 3 2.9 1 1 2 1 1 1 2 2 2 2 1 2 1 1 2 1 1 3 2 6 2 1 1 2 1 2 2 2 2 18 0 pT2N0Mx 1 2 2 2 1 1 1 1 10 1 1 1 1 10 1 1 1 2 2 99 1 2 2 1 90 5 5
29 29 10917/16 46 2 2 2 1 2 3 5 1 1 2 1 2 1 2 2 1 1 1 1 1 2 1 1 2 3 6 2 2 2 2 1 2 2 2 2 11 4 ypT2N2aMx
30 30 29707/15 53 2 2 1 1 1 3 2 1 1 1 2 2 2 1 1 1 1 2 1 1 2 3 6 2 2 2 2 1 2 2 2 2 6 6 NA 1 2
31 31 21535/16 43 2 1 1 1 2 3 4.5 1 1 2 1 1 1 2 2 1 1 1 1 1 2 1 1 3 2 6 2 1 2 1 2 2 2 2 2 18 4 pT2N1aMx 1 1 2 1 40 1 1 1 1 2 5 1 1 1 1 5 1 1 1 2 2 80 1 1 1 2 80 5 5
32 32 38845/15 52 2 2 1 1 2 3 3.5 1 1 2 1 1 1 2 1 1 1 1 2 1 1 2 1 1 2 3 6 2 2 1 2 2 2 2 2 2 10 0 pT2NoMx 1 2 1 1 2 1 1 1 1 1 30 3
33 33 2973/16 44 2 2 1 1 1 3 3.4 1 1 1 1 1 1 2 2 1 1 1 1 1 2 1 1 2 3 6 2 1 1 2 1 2 2 2 2 21 0 ypT2N0Mx 1 2 2
34 34 36092/16 73 2 1 1 1 2 3 3 1 1 2 1 1 1 2 1 1 1 1 1 1 2 1 1 2 3 6 2 1 1 2 1 1 2 2 1 1 2 1 1 2 1 1 2 1 10 1 1 1 1 3 99 1 1 1 3 99 5 5
35 35 5778/161 41 2 2 2 1 1 1 2 1 1 1 2 2 2 1 1 1 1 2 1 2 2 1 5 1 1 1 2 1 2 2 2 2 1 1 2 1 2 1 1 1 1 2 99 1 1 1 2 99 5 5
36 36 5778/162 41 2 1 2 1 1 1 2 1 2 1 2 2 1 1 1 1 1 2 1 1 2 2 5 1 2 2 2 1 2 2 2 2 1 2 1 1 1 1 1 80 5
37 37 11733/16 46 2 1 1 1 1 3 3 1 1 2 1 2 1 2 1 1 1 1 1 1 1 1 1 3 2 6 2 1 1 2 1 1 2 2 2 15 3 pTx(m)N1aMx 1 2
38 38 15992/16 48 2 1 1 1 1 1 2 1 1 1 2 1 1 1 1 1 1 2 1 2 2 1 5 1 2 2 2 2 1 2 2 2 1 2 1 1 2 1 1 1 1 3 90 5
39 39 16503/16 49 2 2 1 1 1 1 2 1 2 1 2 1 1 1 1 1 1 2 1 2 3 1 6 2 1 2 2 2 2 2 2 2 1 2
40 40 22136/16 66 2 1 1 1 1 1 2 1 1 1 2 1 1 1 1 1 1 2 1 1 3 2 6 2 2 2 2 1 2 2 2 2 1 1 1 1 5
41 41 25778/16 35 2 2 1 1 1 1 2 1 2 1 2 1 1 1 1 1 1 2 1 1 3 2 6 2 2 2 2 1 2 2 2 2
42 42 33420/16 48 2 2 1 1 1 1 2 1 1 1 1 1 1 1 1 1 1 2 1 1 3 2 6 2 2 2 2 2 2 2 2 2 1 1 2 2 60
43 43 31586/16 42 2 2 1 1 1 1 2 1 2 1 2 2 1 1 1 1 1 2 1 1 2 2 5 1 1 1 2 1 2 2 2 2 2  
44 44 33446/16 61 2 1 1 1 1 1 2 1 2 1 2 1 1 1 1 1 1 2 5 2 3 2 7 2 2 1 1 2 2 2 2 2
45 45 31445/15 2 1 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 1 2 1 1 3 2 6 2 2 1 2 1 2 2 2 2
46 46 31480/15 41 2 1 1 1 1 3 4.8 1 1 2 1 1 1 2 1 1 1 1 2 1 1 2 1 1 3 2 6 2 1 1 2 1 2 2 2 1 6 1 pT2N1aMx 1 2 1 1 1 5
47 47 26434/14 59 2 1 1 1 1 3 2 1 1 2 1 1 1 2 1 1 1 1 2 1 1 2 1 1 3 2 6 2 1 1 2 1 2 2 2 2
48 48 11856/12 38 2 2 1 1 1 3 1 1 2 2 2 1 2 1 1 1 1 2 1 1 2 1 1 3 2 6 2 1 2 2 1 2 2 2 2
49 49 208/12 64 2 2 1 1 2 3 3.5 1 1 1 1 2 1 2 2 1 1 1 2 1 1 2 1 1 3 2 6 2 1 2 2 2 2 2 2 2 23 0 ypT2N0Mx 1 2 1 2 1 20 2 1 1 1 2 1 10 1 1 1 1 2 99 1 1 1 2 99 5 5
50 50 4923/16 53 2 1 1 1 1 2 3.8 1 1 2 1 1 1 2 1 1 1 1 2 1 1 1 1 1 3 2 6 2 1 1 2 1 2 2 2 2 5 4 pT2N2aMx 1 1 2 2 100 1 2 3 90 2 1 1 2 2 60 2 1 1 1 1 1 2 99 1 1 1 2 90 5 5
51 51 2973/16 44 2 2 1 1 2 3 3.4 1 1 2 1 1 1 2 2 1 1 1 2 1 1 2 1 1 3 2 6 1 1 2 2 1 2 1 2 2 21 0 ypT2N0Mx 2 1 2 1 1 1 1 1 3 99 1 1 1 2 90 5 5
52 52 3611/16 48 2 1 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 1 2 1 1 3 2 6 2 2 2 2 1 2 2 2 2 1 1 1 1 1 40 1 1 1 1 1 10 2
53 53 5065/16 57 2 1 1 1 1 1 2 1 2 1 2 2 2 2 1 2 1 1 2 1 1 3 2 6 2 2 2 2 2 2 2 2 2 1 2 2 1 2 1 1 2 1 2 90 5
54 54 11042/14 67 2 2 1 1 1 1 2 2 2 1 2 2 1 1 1 2 1 1 2 1 1 3 1 5 1 1 2 2 2 2 2 2 2 2 1 2 1 1 1 2 1 1 80 1 2 1 1 90 5 5
55 55 14908/16 39 2 2 1 1 1 5 2 1 1 1 2 1 1 1 1 2 1 1 2 1 1 3 2 6 2 2 2 2 1 2 2 2 2 12 2 NA 1 1 1 2 60 1 1 1 2 1 70 1 1 2 1 2 99 5
56 56 23103/16 49 2 2 1 1 1 1 2 1 1 1 2 2 1 1 1 2 1 1 2 1 1 3 2 6 2 2 2 2 2 2 2 2 2 1 1 1 2 30
57 57 20510/15 72 2 1 1 1 2 3 3.5 1 1 2 1 1 1 2 1 1 1 1 2 1 1 2 1 1 3 2 6 2 2 1 2 1 2 2 2 2 12 5 ypT2N2aMx 1 2
58 58 20860/16 43 2 1 1 1 1 3 2 1 2 1 2 2 1 1 1 2 1 1 2 1 1 3 2 6 2 1 2 2 1 1 2 2 2
59 59 36020/14 65 2 2 1 1 1 1 2 1 2 1 2 1 1 2 1 2 1 1 2 1 1 3 2 6 2 1 2 2 2 2 2 2 2 1 1 1 1 60 2 1 2 1 1 2 1 2 99 1 1 1 1 90 5 5
60 60 34357/15 46 2 1 1 1 1 1 2 1 2 1 2 1 1 1 1 2 1 1 2 1 1 3 2 6 2 2 2 2 1 2 2 2 2 1 2 1 1 1 2 1 5 1 1 2 1 1 50 4
61 61 29707/15 53 2 2 1 1 1 3 1 1 2 1 1 1 2 2 1 1 1 2 1 1 2 1 1 3 2 6 2 2 1 2 1 2 2 2 2 1 2
62 62 35234/15 42 2 1 1 1 1 1 2 1 2 1 2 2 1 1 1 2 1 1 2 1 1 3 2 6 2 2 1 2 1 2 2 2 2 1 1 1 2 5o 1 1 1 2 1 10 1 1 2 1 3 99 5
63 63 41762/14 69 2 1 1 1 1 1 2 1 2 1 2 2 2 2 2 2 1 1 2 1 1 3 2 6 2 2 2 2 1 2 2 2 2 1 2  2 1 1 1 2 1 1 50 4
64 64 12085/13 58 2 1 1 1 1 1 2 1 1 1 2 2 2 1 1 2 1 1 2 1 1 3 2 6 2 2 2 2 1 2 2 2 2 1 2 2 1 1 1 2 1 1 80 5
65 65 49890/14 40 2 1 1 1 1 2 1 2 1 2 1 1 1 1 2 1 1 2 1 1 3 2 6 2 2 2 2 2 2 2 2 2 1 2 2 1 1 1 2 1 2 70 5
66 66 6284/14 49 2 1 1 1 1 3 2 2 2 2 2 2 2 2 2 2 2 2 2 1 2 2 2 2 2 2 2 1 2 1 30 1 1 2 1 40 1 2 1 2 99 5
67 67 1494/15 61 2 2 1 1 1 3 5 1 1 2 1 1 1 2 2 1 1 1 2 1 1 2 1 1 3 2 6 2 2 1 2 1 2 2 2 2 12 1 ypT2N1Mx 2 1 1 1 1 5 1 1 2 1 3 99 5
68 68 14736/14 41 2 1 1 1 1 2 1.9 1 1 2 1 1 1 2 2 1 1 1 2 1 1 2 1 1 3 2 6 2 1 2 2 2 2 2 2 2 1 1 1 1 5 1 1 1 2 1 5 2 1 1 1 2 1 3 99 1 2 1 3 99 5 5
69 69 10598/14 58 2 2 1 1 1 3 2.6 1 1 2 1 1 1 2 2 1 1 1 2 1 1 2 1 1 3 2 6 2 1 1 2 1 2 2 2 2 1 2 1 2 1 5 2 1 1 1 2 1 10 1 1 2 1 2 90 1 2 1 3 99 5 5
70 70 32658/14 64 2 2 1 1 1 1 2 1 1 1 2 2 2 2 1 2 1 1 2 1 1 3 2 6 2 2 2 2 2 2 2 2 2 1 2 2 1 1 1 2 1 1 60 4
71 71 17050/12 54 2 2 1 1 2 3 3.5 1 1 2 1 2 1 2 2 2 1 1 2 1 1 2 1 1 3 2 6 2 2 2 2 1 1 1 2 2 9 6 pT2N2Mx 2 1 1 1 2 1 2 99 1 2 1 3 90 5 5
